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Abstract 
 The complex interactions of signaling molecules, transcription factors, and target 
genes that direct the development of diverse organisms and their component parts are 
known as gene regulatory networks (GRNs).  The Caenorhabditis elegans vulva, with its 
invariant lineage, 22 cells of seven types (vulA, vulB1, vulB2, vulC, vulD, vulE, and 
vulF), and availability of 30 reporter constructs exhibiting a variety of differentiated 
vulval cell expression patterns, provides us with an elegant system for studying a GRN 
directing organogenesis.  Several regulators of vulval differentiation are known (COG-1, 
EGL-38, LIN-11, and LIN-29).  Utilizing the available reporter constructs of genes 
expressed in the maturing vulva allowed me to further define the roles of LIN-11 (LIM 
homeodomain) and LIN-29 (zinc finger).  The heterochronic gene pathway member LIN-
29 was originally thought to play a direct role in the temporal expression of genes in the 
vulva.  The analysis of multiple pairwise interactions between lin-29 (loss of function) 
and members of the vulval GRN, however, has shown that LIN-29’s role is more nuanced 
than previously assumed.  I determined that lin-29 positively regulates lin-11 expression 
and directs a significant aspect of gene expression patterning in the maturing vulva.   
 The known regulators of the vulval network fail to account for all of the 
regulatory interactions required for proper vulval differentiation.  As such, there are 
likely other transcriptional regulators that have not yet been identified.  I took several 
approaches for identifying additional factors.  First, I conducted a screen in a zmp-
1::GFP (zinc metalloproteinase) background by disrupting activity of 836 transcription 
factors by RNA interference (RNAi).  zmp-1 is a readout for differentiation of the vulA, 
vulD, and vulE cells.  This screen identified nhr-67 (ortholog of Drosophila tailless) and 
  vii 
nhr-113 (orphan nuclear hormone receptor) as positive regulators of zmp-1 expression in 
the vulA cells.  nhr-113 appears to have a narrow role in vulval organogenesis; perhaps 
only as a partial regulator of vulA cell differentiation.  Furthering the analysis of zmp-1, I 
utilized a phylogenetic footprinting approach for analyzing the upstream region of C. 
elegans zmp-1, and its homologs in the related species C. briggsae and C. remanei.  This 
analysis identified four conserved motifs upstream of the ZMP-1 translational start site.  
Characterization of these motifs, by deleting them from a zmp-1::GFP transgene, 
revealed that three of these four motifs exhibit cis-regulatory activity. 
 In addition to investigation of zmp-1 regulation, we undertook a parallel study 
where we performed sequence alignment analysis on 17 genes with reported vulval 
expression in combination with in vivo testing.  This identified nine ~ 200-bp vulva-
specific enhancer elements associated with six of these genes.  Yeast one-hybrid analysis 
of six of these enhancer elements isolated six protein-DNA interactions.  Further 
characterization of these interactions uncovered the role of the zinc finger transcription 
factor, ZTF-16, in vulval induction and differentiation.  These results show that by taking 
multiple approaches, including the use of post-genome technologies, we can expand our 
understanding of a gene regulatory network. 
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Gene Regulatory Networks and Development 
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Introduction 
 All metazoans arise initially from single cells that subsequently pass through 
multiple rounds of cell division.  When a cell divides, its progeny each inherit the same 
genetic code, however, these cellular offspring can, and often do, express subsets of 
genes that are divergent from their parent and from each other.  Each cell can assume 
incredibly diverse characteristics of size, shape, and function in spite of the fact that they 
each inherit the same genetic information.  Gene regulatory networks (GRNs) describe 
the complex interactions that account for these differences (1).   
 There are, at a minimum, three components of a gene regulatory network.  First, it 
consists of a system for processing information from either intra- or intercellular 
signaling molecules.  Second, these signaling molecules modulate the expression levels 
of transcription factors (TFs).  Third, target genes are acted upon by these transcription 
factors via cis-regulatory modules, and their expression products, either RNA or protein, 
ultimately account for the functional and structural differences between cells (1–4). 
 Each protein-encoding gene involved in a gene regulatory network is generally 
associated with a core promoter element, enhancers (activating sequences), and silencers 
(repressing sequences).  Other elements may include insulators and barriers.  5’ of the 
transcriptional start site is the core promoter element, an approximately 100 base pair 
(bp) region where the transcriptional machinery binds and transcription is initiated.  
Enhancers are bound by activators which act to increase transcription; while silencers are 
bound by repressors which decrease transcription (5).  The enhancers, silencers, and 
insulators are collectively referred to as cis-regulatory modules, and are often located 
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upstream of the gene-coding sequence, but they have also been identified within intronic 
sequences and even downstream of their concomitant gene.  These modules serve as the 
targets of the transcription factors that operate in a given gene regulatory network, and it 
is through them that the signals that direct the complex patterns of cellular gene 
expression are mediated (3).  
 The details of exactly when, where, and at what levels each gene is expressed are 
represented by the gene regulatory network.  The linkages between genes and their 
targets are the building blocks of the network and reveal how the inherited genomic 
sequence can result in a given function and structure.  These linkages cannot be fully 
appreciated at the level of individual gene-gene interactions, but by stepping back, and 
observing them in the context of multiple interacting subcircuits controlling a complex 
system (cell fate specification, embryogenesis, organogenesis, etc.), their significance can 
be more fully recognized (2, 3). 
 The process of development is extremely complex.  To aid in understanding their 
underlying logic, developmental gene regulatory networks should be analyzed at the level 
of their component modules or subcircuits.  Subcircuits consist of a group of genes and 
cis-regulatory elements that perform a specific developmental “job.”  There are a host of 
common subcircuits including auto and cross regulatory feedback, double-negative gates, 
intra- and intergenic feedback loops, regulatory autorepression, and transcriptional 
exclusion of alternative states (1–3, 6, 7).    
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1.  How and why do we investigate GRNs? 
 BioTapestry (www.biotapestry.org) is an open source software package that aids 
in the computational modeling of gene regulatory networks (8).  This software is useful 
in that it provides a uniform method for representing the architecture of developmental 
GRNs, and it is now utilized by many of the groups working in the field.  Modeling in 
this manner also aids in the cross-species comparison of networks—comparisons that can 
illuminate evolutionary diversification that has occurred among related processes of 
differentiation and patterning (2, 9, 10).  This research also reveals the blueprints for how 
genetic pathways generate different cell types, a central topic of study in the burgeoning 
field of stem cell biology (11, 12).   
  In studying developmental regulatory networks, we uncover the processes that 
account for the extraordinary diversity of cells, tissues, organs, and species that are 
present on Earth.  By thoroughly dissecting these processes we can more fully understand 
how they operate.  A potential benefit of this knowledge is that many of the diseases that 
afflict humans, animals, and plant species involve developmental processes at their core.  
These conditions can potentially be treated or reversed by repairing, disrupting, or 
circumventing defective genetic architecture.  
 
1.1  New Approaches  
 Our understanding of gene regulatory networks is based on the results of many 
different techniques including genetic screens; genetic interaction analysis using mutant 
alleles, overexpression constructs and other tools; reporter assays; and in vitro binding 
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assays.  In addition to these methods, analysis of cis-regulatory modules has typically 
involved labor-intensive molecular biology techniques including sequential deletion and 
dissection of regulatory elements, DNase footprinting assays, and gel-shift analysis.  
Advances in whole-genome techniques in the post-genomic sequencing era are opening 
up new avenues of exploration into gene regulatory networks.  
 
1.1.1  A Genome-Wide Analysis of Kidney Organogenesis   
 An international consortium, the GenitoUrinary Development Molecular 
Anatomy Project (GUDMAP), is using the mouse kidney model for the first genomics-
level analysis of organogenesis (13).  They utilize either fluorescence-activated cell 
sorting (FACS) or laser capture microdissection (LCM) in combination with component-
specific GFP transgenic mice to isolate and purify individual elements of the developing 
kidney.  These techniques allow the consortium to isolate discrete components of the 
kidney at multiple developmental time points.  RNA is then isolated from these samples 
and the transcription profiles are analyzed using microarray technology.   
 The data from this microarray analysis can then be used to identify linkages in the 
gene regulatory network of kidney development.  When genes are expressed in the same 
region and at the same time point it is more likely that they are regulated by the same 
transcription factors.  By determining the distribution of conserved transcription factor-
binding sites in coexpressed genes, a regulatory circuit can be revealed.  In the 
consortium’s analysis of the promoters of genes showing enriched expression in the 
proximal tubule of the nephron, a statistically significant overabundance of HNF1β-
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binding sites were identified.  HNF1β is a homeodomain transcription factor that binds 
DNA either as a homo- or heterodimer.  44 genes were identified as candidate target 
genes of HNF1β due to the enriched presence of HNF1β-binding sites.  One interesting 
putative target gene is the transcription factor HNF4α.  Subsequent analysis revealed a 
further 19 genes in the proximal tubule that are putative targets of HNF4α.  These 
findings suggest a possible regulatory circuit within the proximal tubule, with HNF1β 
regulating HNF4α, and HNF4α regulating at least a subset of these 19 implicated genes.  
These findings show the efficacy of utilizing this type to data to identify additional 
components of a gene regulatory network (13). 
 
1.1.2  Genomic Techniques and Patterning of the Drosophila Embryo   
 The sequence-specific transcription factor Dorsal, a relative of mammalian NF-
κB, controls the asymmetric dorsal-ventral (DV) patterning of the Drosophila embryo.  
Extensive analysis of this process has identified numerous Dorsal target genes and 
allowed for the elucidation of the regulatory framework that directs DV patterning.  The 
recent implementation of several post-genomic technologies has resulted in the 
identification of many more potential Dorsal target genes and members of the dorsal-
ventral patterning gene regulatory network (14). 
 A whole-genome tiling array that contains the entire Drosophila genome is now 
available.  Because tiling arrays include the entire genome, unlike traditional microarrays, 
they are not biased by gene prediction models, and they include nonprotein-coding genes 
such as miRNAs.  Using this technique, Biemer et al. were able to identify 30 additional 
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protein encoding genes and at least two miRNA genes that are regulated by the DV 
gradient (15).  
 Two of the earliest targets of Dorsal in the DV patterning network are the genes 
that encode Twist (basic helix-loop-helix activator) and Snail (zinc-finger repressor).  To 
identify the enhancer elements through which these transcription factors regulate gene 
expression, Zeitlinger et al. used chromatin immunoprecipitation coupled with 
microarray analysis (ChIP-chip).  This analysis identified several hundred additional 
potential target enhancers, many of which are associated with previously unidentified 
target genes.  Confirming the efficacy of this approach, their ChIP-chip analysis 
identified 20 of 22 known target enhancers of Dorsal (16).  The results of the tiling array 
and the ChIP-chip analysis reveal that the entire complement of genes that comprise even 
the most thoroughly studied gene regulatory networks have not yet been identified.  
These techniques, and others at the forefront of genetic research, have now proven their 
potential for greatly enhancing our understanding of genetic regulatory circuitry. 
 
2.  The C. elegans Vulva 
 In addition to the mouse kidney and Drosophila embryo, regulatory networks are 
being investigated in diverse model systems and at various developmental time points 
(see Table 1).  These range from the network controlling environmentally induced 
physiological responses in the free-living, single-celled organism Halobacterium 
salinarum (17) to development of the hindbrain in mouse and chicken (18).  Whereas the 
majority of gene regulatory networks being analyzed in other invertebrates focus 
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primarily on pathways involved in embryogenesis (i.e., germ layer specification in sea 
urchin (19), and specification and patterning of the Drosophila syncytial blastoderm (14, 
20)), the C. elegans vulva provides us with a model that is well-suited for mapping the 
architecture of a gene regulatory network controlling organogenesis.  
 
2.1  Vulval Development 
     The life cycle of C. elegans consists of four larval stages (L1–4) and an adult 
stage, with each stage separated by a molt.  The vulva, which allows for passage of sperm 
and eggs by connecting the uterus to the external environment, is derived 
postembryonically from six vulval precursor cells (VPCs) termed P3.p–P8.p (see Figure 
1).  All six VPCs are competent to receive an inductive signal from a specialized somatic 
gonadal cell, the anchor cell (AC), during the L2 stage.  P6.p, which is closest to the AC, 
is induced to generate the 1˚ vulval lineage, producing the inner cells of the vulva.  The 
P5.p and P7.p cells generate the 2˚ vulval lineages, producing the outer cells of the vulva.  
The P3.p, P4.p, and P8.p are not induced and adopt the 3˚ fate, and fuse to the 
hypodermal syncytium hyp7.  The L4 stage vulva comprises 22 differentiated cells that 
are descendents of P5.p, P6.p, and P7.p.  There are seven different vulval cell types: 
vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF (21). 
 Each vulval cell type has specialized roles that contribute to vulval function and 
morphology.  For example, vulF cells, the innermost vulval cells, contact the AC and the 
uterus.  As such, they are the targets for AC invasion, thus creating the vulval-uterine 
connection required for egg-laying (22).  Vulval muscles that regulate egg-laying connect 
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to the vulva between vulC and vulD, and the outermost portion of the vulva comprises 
the vulA cells, which attach the vulva to the hypodermis (21).  The unique patterns of 
gene expression in each of the vulval cell types are likely responsible for their individual 
properties. 
 
2.2  Vulval Organogenesis as a Model GRN 
 While the organs of many higher species (i.e., the mouse kidney with its roughly 
one million nephrons) may contain hundreds of millions of cells, the C. elegans vulva, as 
described above, contains only 22 cells.  This relative simplicity allows for easier 
identification and mapping of the intra- and intercellular communication that occurs 
during organogenesis.  In spite of this relative simplicity though, the vulva possesses 
many hallmarks of an organ.  It is composed of rudimentary tissue types, specifically its 
seven cell types, and it performs a specialized task.  It also uses several mechanisms that 
are common to organogenesis such as reciprocal inductive interactions and epithelial cell 
polarity.  For example, during vulval organogenesis an inductive interplay between the 
vulva and the gonad results in cell fate specification.  The anchor cell (a specialized cell 
of the somatic gonad) ensures the 1˚ vulval fate (23), and subsequently the vulF (1˚ 
vulval fate cells) induce uv1 cell fate in the gonad (24).  Additionally, epithelial cell 
polarization, as evidenced by the reversed polarity of the 2˚ vulval lineages, has been 
demonstrated by both conserved cell division patterns and gene expression (25).   
 Other key properties of C. elegans include its amenability to genetic 
manipulation, its invariant cell lineage, and its well-characterized genome.  Additional 
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advantages of the vulva as a model for systematic study of organogenesis include that it 
is not essential for viability, thus allowing for the in vivo observation of varied genetic 
perturbations, and that we have access to a wide variety of reporter genes with spatially 
and temporally unique expression patterns in the seven vulva cell types (21, 26).   
 
2.3  Dissection of the Vulval GRN  
 EGF, Notch, and Wnt signaling pathways specify which VPCs generate the 1˚ and 
2˚ lineages (21), but we are just now identifying the network of transcription factors that 
control cell-fate differentiation of the seven vulval cell types.  When I commenced my 
thesis research, four transcription factors had been identified as major regulators of vulval 
cell differentiation and morphogenesis:  lin-11 (LIM homeodomain protein), lin-29 
(C2H2-type zinc finger, heterochronic gene pathway member), cog-1 (Nkx6.1/6.2 
homeoprotein), and egl-38 (Pax2/5/8 protein).  Mutants of these transcription factors 
were originally isolated from ethyl methanesulfonate (EMS) mutagenesis screens and 
subsequently characterized.  The original mutant alleles of lin-11, lin-29, and egl-38 were 
isolated from a large EMS mutagenesis screen (145 fertile mutants) for egg-laying 
defective (Egl) mutants (27).  cog-1(sy275) was isolated from an EMS screen for Egl 
mutants with abnormal late-L3 vulval morphology (28).  These screens, and others like 
them, are biased toward the isolation of mutants with strong morphological defects (i.e., 
protruding vulva, no vulva, etc.) and for those that act nonredundantly.  The C. elegans 
genome encodes approximately 934 known and putative transcription factors (29).  Since 
functions have not been observed for many of these, we find it highly plausible that 
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transcription factors that act redundantly, or that play more subtle roles in vulval 
development exist.  It will likely require novel approaches to old methods and 
implementation of newly developed post-genome techniques to identify these factors.  
 
Thesis Prelude 
 The C. elegans vulva provides us with an excellent opportunity for studying a 
post-embryonic model of organogenesis.  Its level of complexity strikes an elegant 
balance between the almost overwhelming complexity of mammalian organogenesis and 
the relative simplicity of single cell-type differentiation and specification.  My project 
initially focused on the specification of the vulA cells.  I took two different approaches 
for analyzing this process: a reverse genetic screen utilizing an RNA interference (RNAi) 
library, and phylogenetic footprinting coupled with enhancer element dissection. 
 Libraries of RNAi clones consisting of the majority of genes in C. elegans 
genome have become available in the last several years.  We compiled a list of known 
and predicted C. elegans transcription factors and generated a transcription factor RNAi 
library consisting of 836 clones.  I conducted a screen in a zmp-1::GFP (zinc 
metalloproteinase) background using our transcription factor subset of the whole-genome 
RNAi library.  zmp-1 is expressed in the vulA, vulD, and vulE cells, but its vulA 
expression has been shown to be differentially regulated from that in vulD and vulE (26).  
This screen identified nhr-67 (ortholog of Drosophila tailless) and nhr-113 (orphan 
nuclear hormone receptor) as positive regulators of zmp-1 expression in vulA cells.  nhr-
113 appears to have a narrow role in vulval organogenesis; perhaps only as a partial 
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regulator of vulA cell differentiation.  It however, serves as an example of a mutation 
with a subtle phenotype that was less likely to be identified by a traditional mutagenesis 
screen. 
 Furthering our analysis of zmp-1, we used Cistematic to analyze the upstream 
region of C. elegans zmp-1, and its homologs in the related species C. briggsae and C. 
remanei.  Cistematic is a software package that incorporates the phylogenetic-
footprinting and motif-finding capabilities of MEME, AlignACE, Co-Bind, and 
Footprinter for identifying cis-regulatory elements (30).  This scan identified four 
conserved motifs upstream of the ZMP-1 translational start site.  Characterization of 
these motifs, by deleting them from a zmp-1::GFP transgene, revealed that three of these 
four motifs exhibit cis-regulatory activity. 
 The availability of thirty transgenes with a variety of expression patterns in the 
cells of the vulva allowed me to further define the roles of two transcription factors acting 
in the vulval gene regulatory network: lin-11 and lin-29.  The heterochronic gene 
pathway member lin-29 was originally thought to play a direct role in the temporal 
expression of genes in the vulva.  The analysis of multiple pairwise interactions between 
lin-29 and members of the vulval GRN however, has shown that lin-29’s role is more 
nuanced than previously perceived.  We now know that lin-29, at least partially, regulates 
lin-11 expression to direct a major component of vulval cell fate specification. 
 The final aspect of my project further dealt with the concept of cis-regulation of 
transcription, and was done in collaboration with Takao Inoue and Marian Walhout.  We 
were able to use bioinformatics techniques to identify nine ~ 200-bp vulva-specific 
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enhancer elements associated with six genes.  By submitting these sequences to yeast 
one-hybrid analysis we were able to isolate five transcription factors that bind these 
regions in yeast nuclei.  Further investigation of these transcription factors identifies one 
of them as a new member of the vulval gene regulatory network.  These results show that 
by taking multiple approaches, and embracing post-genomic sequencing technologies, 
previously unidentified members of gene regulatory networks can be unveiled. 
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Figure Legend 
Figure 1.  Vulval lineages.  The fates of the six vulval precursor cells (VPCs) are 
specified during the third larval stage (L3).  The 1˚ and 2˚ VPCs divide and generate the 
22 cells of the adult vulva.  The 1˚ lineage generates four vulE and four vulF cells.  The 
2˚ lineage generates four vulA cells, two vulB1 cells, two vulB2 cells, four vulC cells, 
and two vulD cells.  The 3˚ lineage fuses with the hypodermal syncytium hyp7.  L 
indicates a longitudinal axis of cell division; T, transverse axis of cell division; N, no cell 
division.  The underlined Ls indicate where the vulva adheres to the ventral cuticle.  
(Figure taken from Sternberg, WormBook). 
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Figure 1
Figure from Sternberg, WormBook
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Table 1:  A sampling of gene regulatory networks in diverse species 
 
Species Process Reference 
Arabidopsis early flower development (31) 
C. elegans C-lineage specification in the embryo (32) 
C. elegans foregut differentiation (33, 34) 
C. elegans neuron specification (35) 
chicken hindbrain development (18) 
Ciona embryogenesis (36) 
Drosophila Bicoid (Bcd): anterior-posterior patterning of the embryo (20) 
Drosophila bristle patterning on the thorax (9) 
Drosophila Dorsal (Dl): dorsal-ventral patterning of the embryo  (3, 37) 
Halobacterium salinarum physiology of free living cell (17) 
lamprey neural crest formation (38) 
mouse cardiac development (39) 
mouse eye development (40) 
mouse hindbrain development (18) 
mouse pancreatic development (41) 
mouse regulation of gastrula organizer (42) 
mouse renal development (13) 
mouse T lymphocyte fate specification (43) 
sea urchin endomesoderm specification and patterning (19) 
Xenopus mesoderm specification and patterning (44) 
zebrafish mesoderm specification and patterning (45) 
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Abstract 
 The Caenorhabditis elegans vulva is an elegant model for dissecting a gene 
regulatory network (GRN) that directs post-embryonic organogenesis.  The mature vulva 
comprises seven cell types (vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF), each with 
its own unique pattern of spatial and temporal gene expression.  The mechanisms that 
generate the spatially defined pattern of these vulval fates are not well understood. Here 
we describe a provisional transcription factor network that defines some of these discrete 
cell types. Reverse genetic screens identified novel components of the vulval GRN, 
including nhr-113 in vulA. Several transcription factors (lin-11, lin-29, cog-1, egl-38, and 
nhr-67) interact with each other and act in concert to regulate target gene expression in 
the diverse vulval cell types. For example, a pivotal role of egl-38 (Pax2/5/8) is to 
stabilize the vulF fate by positively regulating vulF characteristics and by inhibiting 
characteristics associated with the neighboring vulE cells.  Computational approaches 
have been successfully used to identify functional cis-regulatory motifs in the zmp-1 (zinc 
metalloproteinase) promoter. Collectively, these findings provide an overview of the 
regulatory network architecture for each vulval cell type. 
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Introduction 
 Complex interactions of signaling molecules, transcription factors and effector 
genes direct spatial and temporal patterning during organogenesis (1).  The differentiation 
and morphogenesis of the Caenorhabditis elegans vulva is useful for studying the gene 
regulatory network (GRN) of larval stage organogenesis due to its invariant cell lineage, 
its amenability to genetic manipulation, and the availability of reporter genes with a wide 
variety of spatial and temporal expression patterns in the seven vulval cell types (2).  
Previously we described a regulatory network of interactions between a set of 
evolutionarily conserved transcription factors and an array of genes expressed in the 
differentiated cells of the C. elegans vulva (3).  Here, we briefly review vulval 
development and aspects of the provisional GRN directing its organogenesis.  We then 
refine the network model by synthesizing data gathered by investigating additional 
pairwise interactions, conducting RNAi screens and computationally analyzing gene 
regulatory sequences.  This analysis has uncovered common network themes such as 
boundary formation, combinatorial control, and stable feedback loops. Also, these 
additional data reflect precise spatial and temporal gene expression in an intact organism 
and demonstrate that the overall network architecture is unique for each of the vulval cell 
types. 
 The life cycle of C. elegans consists of four larval stages (L1–4) and an adult 
stage, each stage separated by a molt (2).  The C. elegans vulva is derived post-
embryonically from six vulval precursor cells (VPCs) termed P3.p–P8.p.  All VPCs are 
competent to receive an inductive signal from a specialized somatic gonadal cell, the 
anchor cell (AC), during the L2 stage.  P6.p, which is closest to the AC, is induced to 
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adopt the 1° vulval lineage fate that constitutes the inner portion of the vulva.  The P5.p 
and P7.p cells adopt the 2° fate and give rise to the outer cells of the vulva.  P3.p, P4.p, 
and P8.p are uninduced and adopt the 3° fate by fusing to the hypodermal syncytium 
(hyp7).  The L4 stage vulva comprises 22 differentiated cells that are descendents of 
P5.p, P6.p, and P7.p, and that are of seven different types:  vulA, vulB1, vulB2, vulC, 
vulD, vulE, and vulF (Figure S1).  EGF, Notch and Wnt signaling pathways specify the 
1° and 2° cell fates, but we are just now identifying the network of transcription factors 
that control cell-fate differentiation in the seven vulval cell types (2). 
 The C. elegans vulva allows passage of sperm and eggs by connecting the uterus 
to the outside environment (2).  Each vulval cell type has specialized physiological roles 
that contribute to vulval function and morphology.  For example, vulF cells, the 
innermost vulval cells, contact the AC and the uterus; they are the target for AC invasion, 
thus creating the vulval-uterine connection required for egg-laying (4).  Vulval muscles 
that regulate egg-laying connect to the vulva between vulC and vulD, and the outermost 
portion of the vulva comprises the vulA cells, which attach the vulva to the hypodermis 
(2).  The unique patterns of gene expression in each of the vulval cell types are likely 
responsible for their individual properties.  Comparison of the vulval GRN to those in 
other organisms is necessary for expanding our knowledge of organ development. 
 
Results and Discussion 
Functional Roles of Gene Expression During Vulval Differentiation.  Much is known 
about the signaling network that initiates vulval development and sets up the general 
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pattern of cell differentiation, but our understanding of the GRN that specifies the 
terminal seven vulval cell types is limited (2).  Five transcription factors (lin-11, lin-29, 
cog-1, egl-38, and nhr-67) are major regulators of cell-fate determination and 
morphogenesis in the vulva.  lin-11 encodes a LIM homeodomain protein, a class of 
proteins consisting of a homeodomain and two specialized zinc-fingers called LIM 
domains (5). These proteins have been identified in organisms as diverse as arthropods 
and vertebrates, and functional analyses of LIM homeodomain family members highlight 
their common role in differentiation and pattern formation (6, 7).  lin-29, a C2H2 type 
zinc finger, plays a role in many events occurring at the larva-to-adult transition, 
including terminal differentiation of the seam cells (8), spicule development in the male 
tail (9), vulval morphogenesis (10) and formation of the vulval-uterine-seam cell 
connection (11). cog-1 encodes a Nkx6.1/6.2 homeoprotein transcription factor (12); 
Nkx6.1 proteins in vertebrates have been implicated in neuronal and pancreatic endocrine 
cell formation (13, 14).  egl-38 encodes a Pax2/5/8 protein, which are known to be 
involved in organogenesis; e.g., mouse Pax2 mediates nephrogenesis during kidney 
development (15, 16).  nhr-67 is an ortholog of Drosophila melanogaster tailless (tll) 
(17).  The tailless nuclear hormone receptor plays major roles in determining the 
terminal-specific structures of the Drosophila embryo and in neuronal development (18). 
The pattern of vulval cell types is specified by the differential interactions of the 
transcription factors that operate within each cell (2). 
 We have identified 30 genes dynamically expressed in specific subsets of the cells 
of the mature C. elegans vulva (Table S1 has a complete list).  These genes encode 
transcription factors, guidance cues, proteases, structural proteins, signaling molecules 
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and novel proteins with unknown function.  The physiological relevance is known for 
several genes.  For example, egl-17, which encodes a fibroblast growth factor (FGF)-
related ligand, is necessary for migration of the sex myoblasts to the vulva (19).  
Induction of the uterine uv1 cells depends on the epidermal growth factor (EGF) family 
member lin-3 (20).  bam-2 (neurexin-related transmembrane protein) and syg-2 
(transmembrane immunoglobulin superfamily protein) are required for vulval innervation 
(21, 22).  sqv-4, which encodes an UDP-glucose dehydrogenase-related protein, is 
involved in the structural integrity and morphology of the vulva (23).  The significance of 
some of the genes expressed in the vulva is not yet known, including: the Drosophila 
empty spiracles (ems) homolog ceh-2 (24), a cadherin-related protein encoded by cdh-3 
(25), and zmp-1 which encodes a zinc metalloproteinase (MT4-MMP-related) (24, 26).  
Genetic perturbations that result in altered expression patterns of these effector genes are 
helpful in elucidating the regulatory network controlling vulval organogenesis. 
 Several additional genes with detectable expression in the mature vulva, including 
two putative transcription factors, have been identified since we last described the vulval 
GRN (3).  The Pax2/5/8 gene pax-2 is expressed exclusively in the vulD cells (17).  pax-2 
is the result of a recent duplication of the egl-38 gene (26).  egl-38, described above, has 
been previously identified as a regulator of cell-fate specification in the C. elegans vulva 
(3, 16, 20).   lin-39 encodes a Hox protein that is an ortholog of Drosophila Sex combs 
reduced (Scr) (27, 28).  lin-39 is required for proper acquisition of 1°, 2° and 3° vulval 
fates (29, 30).  During the late L3 stage, lin-39 expression increases in the vulA precursor 
cells; this expression persists in vulA until late L4 (31).  The Patched-related protein 
DAF-6 is expressed in vulE and vulF (32).  Hao et al. reported the expression of seven 
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hedgehog-related genes in the vulva: grd-5 in vulB and vulD, grd-12 in vulC, grl-4 in 
vulA and vulB, grl-10 in vulA and vulB, grl-15 in vulB, vulC, vulD, and vulE, grl-25 in 
vulA, and grl-31 in vulF (33).  Lastly, nas-37 (34), which encodes a metalloprotease, is 
expressed in vulB (data not shown). 
 
Conserved Regulatory Strategies in the Vulval GRN.  Previously we described how 
the expression patterns of a subset of reporter constructs are affected in transcription 
factor mutant backgrounds (3).  We have increased the number of known interactions 
more than twofold, from 15 to 36, and also identified many of the regulatory relationships 
among the transcription factors (Table 1, Figure S2 and Table S2).  This network includes 
strategies that are shared by other GRNs.  For example, the cell-type specific expression 
of cog-1 appears to be restricted to the vulC and vulD cells by a variety of mutual and 
autoregulatory controls (17).  In a second example, lin-11 is necessary for vulA-specific 
expression of nhr-67 (17).  In turn, nhr-67 is necessary for the expression of the vulA 
effector gene zmp-1.  The differentiated state of vulA may be further stabilized, since 
nhr-67 is positively autoregulated in vulA.  This is an instance where multiple positive 
inputs, including feedback loops, ensure the maintenance of a terminal cell fate.   
 Other network strategies that are present in the vulva include combinatorial 
control circuits.  egl-17 expression in vulF is not perturbed by either cog-1 or egl-38 
mutants (17).  Simultaneous deletion of both genes, however, leads to derepression of 
egl-17 expression in vulF.  This redundancy possibly acts to ensure proper execution of 
cell fate.  Finally, negative autoregulation, as in cog-1 in vulA, vulB, vulE, and vulF and 
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nhr-67 in vulC, vulD, vulE, and vulF, appears to be a fundamental strategy employed in 
the vulval GRN (17).  Negative autoregulation has been found to accelerate gene circuit 
response time and assists in making quick cell fate decisions (35).  This is analogous to 
an automobile: the better the brakes, the faster it can travel between stop signs. 
 
LIN-29 and LIN-11 Interact to Determine Vulval Cell Fate.  By examining the effects 
of specific transcription factor mutations on a wider array of genes expressed in the 
mature vulva, we have found that the roles of some transcription factors in the vulval 
GRN are more complex than previously suspected.  We originally classified lin-29 as a 
potential temporal regulator of gene expression because it is required for vulval gene 
expression at the mid to late L4 stage (egl-17 in vulC and vulD, ceh-2 in vulC, and zmp-1 
in vulD and vulE) (3, 24), and it is known to function in a variety of developmental 
processes that occur at the transition from the L4 to adult stages (8–11).  The above 
scenario is not as straightforward as originally perceived, because we now know that in a 
lin-29 mutant background the mid-L4 expression of lin-3 in vulF cells is not abolished, 
while expression of dhs-31, which is initiated in gravid adults, is abolished (Table 1, 
Figure S2). 
 We also show that LIN-29 is necessary for wild type levels of lin-11 transgene 
expression, and is thus a key regulator of lin-11 (Table 1).  In addition to genes described 
previously (3), lin-11 is also required for dhs-31, egl-26, lin-3, and pepm-1 expression 
(Table 1).  These data reinforce that, of the known transcription factors, lin-11 exhibits 
the broadest effect on cell-type specific expression in the vulva (3).  To date, egl-17 
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during L3 and cdh-3 in vulF are the only vulva expression patterns not abolished in a lin-
11 background. Reporter constructs are powerful tools for identifying genes’ spatial and 
temporal expression patterns.  It should be noted, however, that they exhibit limitations, 
in particular, relevant regulatory motifs may be lacking.  Consequently, it is conceivable 
that the reporter constructs tested in lin-11 and lin-29 backgrounds lack their full 
complement of repressor elements, and as such the pairwise interactions tested may not 
reveal all regulatory activity.   
 The interplay between lin-11, lin-29, and their downstream targets is complex.  
lin-11::GFP expression is not completely abolished in a lin-29 mutant background, and 
several of the gene expression patterns perturbed by loss of lin-11 are not affected in a 
lin-29 deficient background (Figure S2).  It is possible that LIN-29 acts in concert with 
another, as yet unidentified, factor to ensure the proper temporal and spatial expression of 
the general cell-fate regulator LIN-11.  Considering LIN-29’s role as a regulator of 
developmental timing, it seems logical to postulate that it could serve as a temporal input, 
while another factor served as the spatial input.   
 
Identification of Additional Components of the Vulval GRN.  Transcription factors 
identified by forward genetic screens are biased by ascertainment toward those with 
strong, nonredundant effects, as well as those that affect multiple aspects of vulval 
development.  Two categories of transcription factors are relatively more difficult to 
identify in genetic screens.  Mutations that result in lethality or other severe defects will 
not be identified for roles that a partial loss of function mutation might reveal in post-
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embryonic development.  Conversely, genes with more subtle developmental phenotypes 
are also more likely to be overlooked.  We identified genes in both these categories by 
RNA interference (RNAi) screens of known and predicted transcription factors.  One of 
these screens (475 transcription factors, Table S3) was conducted in a ceh-2::YFP 
background, a readout for vulB fate during the L4 stage, and identified nhr-67 (tailless) 
(17).  Since nhr-67 deletion mutants die as young larvae, its role in vulval development 
was not previously identified.  RNAi often causes a partial-loss-of-function phenotype 
instead of a null phenotype.  It can also serve as a temporal or conditional downregulator 
of gene function.  In the case of nhr-67, the larval lethality phenotype was bypassed since 
RNAi was administered to L1 larvae, thus making its vulval phenotypes visible.   
 The second screen (836 transcription factors, Table S4) was conducted in a zmp-
1::GFP background, focusing on perturbations of vulA expression.  This screen also 
identified nhr-67, and the orphan nuclear hormone receptor nhr-113 as positive regulators 
of zmp-1 expression in vulA cells.  nhr-113 might have a narrow role in vulval 
organogenesis since nhr-113 RNAi has no effect on the regulation of several other genes:  
cdh-3, ceh-2, dhs-31, lin-3, or pepm-1 (data not shown).  These results, however, show 
that RNAi screens can identify new components of GRNs. 
 
Differentiation of Discrete 1° Vulval Cell Fates.  The 1° lineage of the vulva generates 
four vulE and four vulF cells.  A signal from the AC and a Wnt signal are required for 
proper specification of these cell fates (36).  The GRN, however, that acts downstream of 
these intercellular signals to guide differentiation of vulE and vulF fates is not known. 
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egl-38::GFP is detectable solely in the vulF cells (37); but analysis of the mutant egl-38 
with nhr-67 RNAi and mutant cog-1 shows that egl-38 not only functions in vulF cells, 
but also inhibits both ceh-2 and egl-17 expression in vulE (17) as well as vulF (3).  
Consequently, egl-38, cog-1 and nhr-67 enforce spatial boundaries by preventing the 2° 
cell-fate associated genes ceh-2 and egl-17 from being expressed in 1° cells (Figure S2, 
vulE and vulF). 
 It was previously speculated that the vulF cells, which are nearer the AC, have 
higher levels of nhr-67 activity versus cog-1, while vulE cells have higher levels of cog-1 
than nhr-67 (17).  The recent availability of an egl-38::GFP reporter has allowed us to 
dissect further the GRN controlling the vulE versus vulF fates.  egl-38 expression in the 
vulF cells is positively regulated by nhr-67 (Figure 1).  egl-38 expression in the vulF cells 
is necessary for specification of the uv1 fate via regulation of the vulF specific gene lin-3, 
thus allowing for the proper development of a vulval-uterine connection (20).  
Conversely, zmp-1 is expressed in vulE but not vulF, and egl-38 is required for inhibiting 
zmp-1 expression in the vulF cells (3). In vulE cells, where egl-38 expression is absent, 
lin-3 is not expressed and cog-1 activated expression of zmp-1 is observed (20).  egl-38 
expression is unaffected in a cog-1(sy275) background, but in an egl-38(n578) 
background egl-38::GFP expression is decreased, suggesting that egl-38 positively 
autoregulates in vulF (Figure 1).  Therefore, egl-38 appears to stabilize vulF fate by 
repressing vulE characteristics and by reinforcing its own expression (Figure 2). 
 In the vulE and vulF cells, cog-1 and nhr-67 negatively regulate both each other 
and themselves (17).  We previously speculated that this might allow 1° cells to rapidly 
switch their fates upon altered intra- and intercellular inputs.  Presumptive vulE cells can 
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induce uterine uv1 fate specification in the absence of vulF cells, thus ensuring the 
establishment of a proper vulval-uterine connection (20).  These observations fit a model 
in which presumptive vulE and vulF cells are bipotential and postitional cues help specify 
their fates.  In this model, vulE, would then be biased for increased nhr-67 activity in the 
absence of vulF.  egl-38 levels would thus increase, and vulF characteristics would be 
activated, while vulE characteristics would be inhibited.   
 
Dissection of zmp-1 Regulatory Elements.  The vulA cells occupy a unique position in 
the vulva in that they form the outermost ring of cells and fuse to the surrounding 
hypodermal syncytium.  zmp-1 (zinc metalloproteinase) is first expressed in vulD and 
vulE cells beginning at the late L4 stage, and in the vulA cells at the L4 to adult transition 
(24).  The fact that vulA-specific expression of zmp-1 is initiated in a different temporal 
window than its expression in vulD and vulE is particularly interesting, because in a lin-
29 background vulD and vulE expression is abolished yet vulA expression is unaffected.  
Since lin-29 affects early zmp-1 expression (vulD and vulE) but not late expression 
(vulA), and since lin-29 temporally regulates gene expression, it seems likely that 
modular cis-regulatory elements drive zmp-1 expression. 
 A 386-bp fragment of upstream intergenic sequence (mk50-51) is sufficient to 
drive vulA and vulE expression, but not the vulD-specific expression of zmp-1 (38).  To 
computationally analyze zmp-1 regulatory sequences defined by this transgenic reporter 
gene analysis we used Cistematic (39).  This software incorporates the motif-finding and 
phylogenetic footprinting capabilities of MEME, AlignACE, Co-Bind and FootPrinter to 
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identify cis-regulatory elements.  Specifically, we analyzed the intergenic region 
upstream of zmp-1 and its orthologs in C. briggsae (CBG09053) and C. remanei 
(CRE04503).  Addition of the C. remanei genome refined the identification of cis-
regulatory motifs in the zmp-1 upstream region (Table 2, Figure S3).  This analysis 
identified three motifs within the mk50-51 zmp-1 enhancer element, and a fourth motif 
five base pairs upstream.  We deleted the instances of the motifs via site-directed 
mutagenesis and analyzed their effects on zmp-1 reporter expression.  Deletion of 
element 103/4 decreased vulA expression and abolished vulE expression. Previous cis-
regulatory studies did not identify an element competent to drive vulA expression in the 
absence of vulE.  Deletion of element 107/8 decreased vulA and vulE expression of zmp-
1::GFP.  Deletion of element 105/6, however, resulted in ectopic expression of mk50-51 
zmp-1::GFP in vulC, vulD, and vulF.  Thus, these elements likely act as positive (103/4, 
107/8) and negative (105/6) regulatory sites for controlling of zmp-1 expression.  While 
we are only beginning to define cis-regulatory architecture of vulval specific gene 
expression, the availability of additional genomes for computational analysis should 
accelerate this process.     
 
Conclusion 
 The regulatory architecture of the vulval GRN differs in all seven cell types.  We 
postulate that this accounts for the differences in vulval cell fate, function, and 
morphology.  We find that the differentiation and organogenesis of the C. elegans vulva 
utilizes several types of gene regulatory strategies that have been identified in other 
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networks.  For example, COG-1 participates in a network of mutual inhibitions with 
NHR-67 in the 1° vulval cells to differentiate between the vulE and vulF fates.  This is 
reminiscent of the cross-inhibitory interaction of COG-1 and DIE-1 in the C. elegans 
ASE neurons (40).   Vertebrate COG-1 homologs, the homeodomain proteins Nkx6.1 and 
Nkx6.2, also appear to act in a similar manner (3).  These proteins interact with the 
transcription factors Dbx1 and Dbx2 in a network of mutual inhibitions to specify motor 
neuron and interneuron fates during neural tube development (15).  In another example, 
lin-11 function is necessary for EGL-17 (FGF) expression in the vulva.  An analogous 
network interaction is present during heart development in mice.  Isl1, which, like lin-11, 
is a LIM homeodomain transcription factor, is required for the expression of FGFs (41).    
 We also describe new interactions within the vulva that may aid in the 
understanding of analogous regulatory interactions in other transcriptional networks, 
since the majority of the transcription factors and effectors present in this GRN have 
relatives in a diverse array of organisms.  These interactions include positive regulation 
of lin-11 by the heterochronic transcription factor LIN-29, lin-3 (EGF) by LIN-11, and 
egl-38 (Pax2/5/8) by NHR-67 (tailless). Our increased knowledge of the roles of 
transcription factors such as lin-11 (LIM homeodomain) and egl-38 (Pax2/5/8) may help 
to further characterize other GRNs.  For example, a LIM homeodomain protein (Lim1) 
and a Pax2/5/8 protein (Pax2) are involved in murine kidney development (42).  Thus the 
GRN that directs nephrogenesis in mice appears to share at least two components with 
the  vulval network in C. elegans.  Our understanding of the kidney morphogensis GRN 
in mammals may be enhanced by investigating the mouse orthologs of other components 
of the vulval GRN. 
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 New approaches are needed to elucidate all the constituents of the complex 
regulatory architecture that directs organogenesis.  Until now, most of the key players in 
vulval organogenesis have been isolated using traditional mutagenesis screens.  These 
types of screens, however, are often limited to identifying only those factors with severe 
phenotypes.  To account for the regulation of all genes that are expressed and function 
during vulva development it is apparent that other members of the vulval GRN are yet to 
be identified.  There are transcription factors with major and minor effects.  For example, 
LIN-11 is required in two tissues for egg-laying and regulates gene expression in multiple 
vulval cell types.  By contrast, using an RNAi screen we were able to identify NHR-113, 
a factor that is possibly only required for fine-tuning gene expression in the vulA cells. 
 Analysis of the effects of various genetic perturbations on vulval organogenesis 
has revealed detailed spatial and temporal distinctions in the regulation of diverse yet 
related cell types.  Our approach provides for precise and accurate study of gene 
expression in an intact organism, and unveils the distinct network architecture in the 
different cell types.  Further dissection of the genomic network within the differentiated 
cell types would extend our knowledge of vulval organogenesis and could also provide 
further insights into organogenesis in other systems.   
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Materials and Methods 
Genetics and RNAi. C. elegans strains were grown and constructed using standard 
protocols (43, 44).  Reporter transgenes used were cdh-3::CFP [syIs51] (24), dhs-
31::YFP formerly known as T04B2.6 [sysIs101] (24), egl-26::GFP [kuIs36] (45), egl-
38::GFP [guEx877] (gift from Chamberlin lab) (37), lin-3::GFP [syIs107] (46), lin-
11::GFP [syIs80] (47), pepm-1::GFP formerly known as F47B8.6 [syIs61] (24), unc-
53::GFP [bgEx11] (48), unc-53::GFP [syEx756], mk50-51 zmp-1::GFP [syEx1012], 
mk50-51 motif 103/4∆ zmp-1::GFP [syEx1009], mk50-51 motif 105/6∆ zmp-1::GFP 
[syEx1091], and mk50-51 motif 107/8∆ zmp-1::GFP [syEx1018].  Alleles used were 
LGI, lin-11(n389); LGII, cog-1(sy275), egl-38(n578), lin-29(n333), lin-29(sy292); LGIV, 
egl-38(n578). 
 nhr-67 RNAi by feeding was used in this study because the mutant allele ok631 is 
lethal at the L1 stage (International C. elegans Knockout Consortium).  The protocol used 
was described previously (17). 
 
Generation of reporter transgenes.  syEx1009, syEx1091 and syEx1018 were generated 
by deleting one motif each, 103/4 (5’-CGAGTACGTTTACAC-3’), 105/6 (5’-
GTACGTATTGCTT-3’), or 107/8 (5’-AGAAAAAGTAGAAGG-3’), respectively, from 
the mk50-51 construct and replacing the motif with a SacII restriction site. Forward 
primer TOR109 (5’-CAAATGGCGATTACCGTTGATGTTGAAGTGGC-3’) lies 
upstream of a SpeI site in the mk50-51 construct and approximately 4 kb upstream of the 
motifs, and reverse primer TOR110 (5’-
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CATATCCTGATCTTCCAGATAACTGCCGTCAC-3’) lies downstream of a PstI site 
in the mk50-51 construct and approximately 2.5 kb downstream of the motifs.  To 
generate a construct with deleted motif 103/4, two primers were designed: TOR104 (5’-
GTGTCGCCGCGGAATACTTTGATGATCAATACAG-3’) is a reverse primer directly 
upstream of the motif and engineered with a SacII restriction site and six bases of spacer 
sequence; TOR103 (5’-GAATACCCGCGGTGGTTTCTGTTCTTTCCGTTT-3’) is a 
forward primer directly downstream of the motif that is also engineered with a SacII site 
and six bases of spacer sequence.  Using mk50-51 as the template, two PCRs were 
conducted using the following primer pairs:  TOR109/104 and 103/110.  Each PCR 
product was then digested with SacII.  The TOR109/104 product was then ligated to 
103/110.  This produced a ligation construct with motif 103/4 replaced by a SacII site.  
The ligation product was then PCR amplified using the TOR109/110 primer pair.  The 
resulting product, and mk50-51 were subsequently digested with both SpeI and PstI.  The 
digested PCR product was then ligated with the digested mk50-51 to generate the 
deletion construct.  The 105/6 and 107/8 deletion constructs were generated by the same 
method using the following primers:  TOR106 (5’-
GTATCACCGCGGACATGAATCAGTTTGCATCTG-3’), TOR105 (5’-
GACTCGCCGCGGGAAAAAAAGAGTAACAAGAAAAAG-3’), TOR108 (5’-
GTATCCCCGCGGTGTTACTCTTTTTTTCAAGC-3’) and TOR107 (5’-
GAATCCCCGCGGGTATTAGTCGTAGTAGTAGTAT-3’). These constructs were then 
individually injected into the gonads of unc-119(ed4); him-5(e1490) animals (49) using 
unc-119(+) (50) and pBSK+ (Stratagene).  syEx756 and syEx1012 were generated by 
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injecting the constructs pNP10 (48) and mk50-51 (38), respectively, into a unc-119(ed4); 
him-5(e1490) background. 
 
Microscopy.  3 mM levamisole was used to anesthetize transgenic animals for 
observation using Nomarski DIC optics (http://www.nomarski.com).  Images were 
captured with a monochrome Hamamatsu Orca II digital camera 
(http://www.hamamatsu.com) and Improvision Openlab 4.0.4 software 
(http://www.improvision.com).  The fluorescent images were overlaid with their 
respective DIC images using Adobe Photoshop 7.0.1 (http://www.adobe.com). 
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Figure Legends 
Figure 1.  egl-38 expression in the vulF cells is dependent on several regulatory 
inputs.  (A–C) Nomarski (left), fluorescence (center), and overlaid (right).  All animals 
displayed carry the egl-38::GFP [guEx877] transgene in their background.  (A) In wild 
type animals, egl-38 is detected exclusively in the vulF cells (arrows).  (B) nhr-67 RNAi 
results in the abolition of egl-38 expression in the vulF cells (arrows).  (C) egl-38(n578) 
mutants lose the ability to positively autoregulate their expression levels in vulF (arrows). 
 
Figure 2.  Differentiation of vulE vs. vulF.  The positions of the vulE and vulF cells 
relative to the anchor cell (AC) are shown.  vulF is closer spatially than vulE to the AC.  
The network diagram was generated using BioTapestry Editor 2.1.0 
(http://www.biotapestry.org) (51).  Linkages with arrowheads represent positive inputs 
and linkages with bar-heads represent repressor inputs for target gene expression.  Black 
font indicates detectable expression levels and gray font indicates no detectable 
expression.  This model presumes that nhr-67 acts in the AC to differentiate between 
vulE and vulF cells.  Signal X could be Ras, Wnt or some other signaling pathway.  The 
blue linkage in vulF is indicated by a thicker line than the blue linkage in vulE because it 
is hypothesized that vulF receives higher levels of signal X-mediated nhr-67 signal from 
the AC.  The thick purple and pink linkages highlight differences in the network 
architecture between the vulE and vulF cells, respectively.  
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Figure S1.  Development of the vulva.  The VPCs divide once during early L3 resulting 
in the VPC daughters.  The P5.p, P6.p, and P7.p daughters then divide again during mid-
L3 to form the VPC granddaughters.  During late L3 each of these cells, except D, divide 
again to create the VPC great granddaughter cells which constitute the mature vulva.  The 
vulval cell types vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF migrate during the L4 
stage as the vulva assumes its adult morphology. 
 
Figure S2.  GRN for C. elegans vulval development.  The vulval GRN is divided into 
the cell types that comprise the vulva: vulA, vulB1/B2, vulC, vulD, vulE, and vulF.  Cells 
with blue backgrounds arise from the 1° lineage and cells with green backgrounds arise 
from 2° lineages.  cog-1, egl-38, lin-11, lin-29, and nhr-67 regulate gene expression in 
the vulval cells and are clustered on the left in each frame.  The remaining genes, 
clustered to the right in each frame and highlighted by colored boxes, are the genes that 
are expressed in the vulva in defined spatial and temporal patterns.  The colored boxes 
highlighting these genes indicate when each gene’s expression is first visualized.  With 
the exception of egl-17 expression in vulE and vulF, the expression of all reporter genes 
persists into adulthood.  egl-17 reporter transgene expression in vulE and vulF appears 
during the L3 stage and turns off during the early L4 stage, while the vulC and vulD 
expression appears during the mid-L4 stage and persists into adulthood.  Light yellow 
squares indicate genes expressed beginning at early L4, yellow squares at mid L4, light 
green squares at late L4, and brown squares at adulthood as indicated.  Not all of the 
genes are expressed at the same time in each cell type.  For example, zmp-1 is expressed 
in vulD and vulE at late L4, but it is not expressed until adulthood in vulA.  Black font 
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indicates genes with detectable expression in a given cell type.  Gray font indicates genes 
without detectable expression in a given cell type but that have been shown to have 
function in the cell type.  In vulA, for example, cog-1 reporter gene expression has not 
been identified, but in the cog-1 mutant background cog-1 expression is visible.  
Linkages with arrowheads indicate positive regulatory activity and linkages with bar-
heads indicate repressor activity.  We do not know if any of these linkages are direct. 
 
Figure S3.  Mutation of conserved subregions of the zmp-1 vulval expression module 
differentially effect its expression.  Several transcriptional reporter constructs 
containing a 386-bp enhancer element (blue box) located 2 kb upstream of the 
presumptive zmp-1 translational start site (black arrow) were generated.  The black boxes 
indicate exons.  The orange, red, and purple rectangles indicate conserved motifs 
identified by Cistematic.  Construct mk50-51 includes the vulval expression module 
attached to minimal Δpes-10::GFP.  The green arrow indicates the GFP translational start 
site.  Construct 103/4Δ is the same as mk50-51 except the motif CGAGTACGTTTACAC 
was deleted.  In construct 105/6Δ the motif GTACGTATTGCTT was deleted.  In 
construct 107/8Δ the motif AGAAAAAGTAGAAGG was deleted.  In each deletion 
construct the deleted motif was replaced by a SacII restriction site. 
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∆pes-10:: GFP motif 103/4∆ CGAGTACGTTTACAC
∆pes-10:: GFP motif 105/6∆ GTACGTATTGCTT
∆pes-10:: GFP motif 107/8∆ AGAAAAAGTAGAAGG
∆pes-10:: GFP
2035 bp2421 bp
2338 bp 2323 bp
2267 bp 2254 bp
2238 bp 2223 bp
Figure S3
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Reporter Mutation vulA vulB1 vulB2 vulC vulD vulE vulF n
dhs-31 + 0 100 100 0 100 0 0 31
dhs-31 lin-11(n389) 0 0* 0* 0 0* 0 0 28
dhs-31 lin-29(sy292) 0 0* 0* 0 0* 0 0 42
egl-26 + 0 61 30 0 61 30 0 37
egl-26 lin-11(n389) 0 0* 1† 0 0* 1† 0 39
lin-3 + 0 0 0 0 0 0 98 26
lin-3 lin-11(n389) 0 0 0 0 0 0 7* 22
lin-3 lin-29(n333) 0 0 0 0 0 0 81 18
lin-11 + 41 92 90 81 100 0 0 38
lin-11 lin-29(sy292) 5* 43* 59‡ 30* 58* 0 0 52
pepm-1 + 0 0 0 91 91 95 95 22
pepm-1 lin-11(n389) 0 0 0 0* 0* 0* 0* 50
pepm-1 lin-29(sy292) 0§ 0§ 0§ 67§ 67§ 67§ 67§ 55
unc-53 + 0 0 0 100 0 0 0 many
unc-53 lin-29(sy292) 0 0 0 80 0 0 0 20
Percentages of cells that express dhs-31::YFP, egl-26::GFP, lin-3::GFP, lin-
11::GFP, pepm-1::GFP, and unc-53::GFP.  Boldface indicates P values are 
significantly different than wild type.  *, P < 0.0001; †, P = 0.0013; ‡, P = 0.0019.  
§pepm-1::GFP is not detectable until the end of the fourth larval stage, at this 
point the vulva has already protruded in lin-29(sy292) mutants making it difficult to 
distinguish between the vulval cell types.                       
Table 1.  Expression of dhs-31, egl-26, lin-3, lin-11, pepm-1, and unc-53 in 
the vulva
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Construct vulA, % (n) vulC, % (n) vulD, % (n) vulE, % (n) vulF, % (n)
mk50-51 86 (28) 0 (35) 0 (35) 89 (35) 0 (35)
103/4Δ 34* (29) 0 (41) 0 (41) 0† (41) 0 (41)
105/6Δ 72 (32) 4 (46) 22‡ (46) 30† (46) 7 (46)
107/8Δ 15† (27) 0 (31) 0 (31) 6† (31) 0 (31)
Shown are percentage of cells that express the indicated constructs.  Values in 
bold indicate P values that are significantly different than wild type.  *, P = 
0.0001; †, P < 0.0001; ‡, P = 0.0040
Table 2.  Expression of mutated zmp-1 enhancers in the vulva
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Gene Description
B0034.1 unfamiliar protein
bam-2 neurexin-related transmembrane protein
C55C3.5 unfamiliar protein
cdh-3 cadherin-related
ceh-2 Drosophila empty spiracles (ems)
cog-1 Nkx6.1/6.2
daf-6 Patched-related
dhs-31 predicted short chain-type dehydrogenase
egl-17 fibroblast growth factor (FGF)-related ligand









lin-3 epidermal growth factor (EGF)
lin-11 LIM homeodomain
lin-29 C2H2 type zinc finger
lin-39 Drosophila Sex combs reduced (Scr)
nas-37 metalloprotease
nhr-67 Drosophila tailless (tll)
pax-2 Pax2/5/8 
pepm-1 protein with M1 peptidase domain
sqv-4 UDP-glucose dehydrogenase-related
syg-2 Immunoglobulin superfamily transmembrane protein
unc-53 novel protein with SH3- and actin-binding sites
zmp-1 zinc metalloproteinase (MT4-MMP-related)
Table S1.  Genes with detectable and dynamic expression in 
subsets of the cells that comprise the C. elegans vulva
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Reporter RNAi vulA vulB1 vulB2 vulC vulD vulE vulF n
cdh-3 + 0 0 0 100 100 100 100 many
cdh-3 nhr-67 0 0 0 100 100 100 100 42
dhs-31 + 0 100 100 0 100 0 0 31
dhs-31 nhr-67 0 100 100 0 100 0 0 27
unc-53 + 0 0 0 84 20 0 0 39
unc-53 nhr-67 0 0 0 76 28 0 0 39
Percentages of cells that express cdh-3::CFP, dhs-31::YFP, and unc-
53::GFP
Table S2.  Expression of cdh-3, dhs-31, and unc-53 in the vulva
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Gene Coordinates Gene Coordinates Gene Coordinates
aha-1 I-5I09 C49C3.5 IV-8C12 eat-1 IV-4D13
ahr-1 I-4P19 C49D10.9 II-3H07 egl-13 X-3I21
ahr-1 I-4P21 C50B6.8 V-8F10 egl-13 X-3K13
arx-6 III-2B15 C52B9.2 X-2H15 egl-18 IV-1H19
asc-1 II-9K18 C54E10.5 V-12C10 egl-27 II-5A22
B0281.3 II-2O24 ceh-10 III-3E03 egl-27 II-5A24
B0336.13 III-3A19 ceh-13 III-4C05 egl-38 IV-5E04
B0379.4a I-5E11 ceh-14 X-3N08 egl-43 II-7G07
B0496.7 IV-3P19 ceh-16 III-4H21 egl-44 II-4B10
B0496.8 IV-3P21 ceh-17 I-2A09 egl-46 V-4L02 
brf-1 II-5F13 ceh-18 X-2O02 egl-5 III-4I05
C01B12.2 II-1A05 ceh-2 I-2HO8 egl-9 V-7A24 
C02B8.4 X-4M03 ceh-20 III-3N09 egr-1 V-3C14
C02F12.5 X-2I14 ceh-21 X-1L01 elt-1 IV-5A05
C03D6.5 I-4F24 ceh-22 V-7I18 elt-2 X-5I11 
C03G6.12 V-5E24 ceh-23 III-4I23 elt-3 X-6D13 
C06E1.8 III-4H13 ceh-24 V-9G15 elt-6 IV-1J07
C07E3.6 II-7C14 ceh-26 III-4A18 end-1 V-9A08
C09F5.3 III-1M23 ceh-28 X-6K07 eor-2 X-6F06
C09G12.1 IV-1H14 ceh-31 X-2E23 F01G4.1 IV-5N06
C09H10.6 II-7L11 ceh-32 V-7N10 F10C1.5 II-4J17
C12D12.5 X-2C18 ceh-33 V-4M17 F16H9.2 X-6C21
C13C4.1 V-8K03 ceh-34 V-4M15 F17A2.3 X-5J12 
C14C6.4 V-1C02 ceh-35 V-9O12 F17A9.6 V-4H19
C16A3.7 III-3K10 ceh-36 X-6L03 F19F10.1 V-5B09 
C17A2.1 II-3D23 ceh-37 X-6L05 F19F10.5 V-5B17 
C17H12.9 IV-3G22 ceh-40 X-5J16 F20D12.5 IV-4E09
C18B12.3 X-6P20 ceh-41 X-1J23 F22A3.1 X-3B11
C25E10.1 V-6I22 ceh-43 III-2A12 F22A3.5 X-3B19
C25G4.4 IV-6J23 ceh-5 I-4J02 F22D6.2 I-3O20
C26B2.4 IV-4G13 ceh-6 I-4M15 F22F1.3 X-4M15
C26C6.6 I-3P23 ceh-7 II-6G20 F25H5.1 I-4F03
C27C12.6 X-6L10 ceh-8 I-4E11 F28C6.2 II-6C06
C27D6.4 II-4A22 ces-1 I-4C10 F28F5.3 III-3H13
C28A5.4 III-2A12 ces-2 I-7M02 F29G9.4 V-4F03
C28H8.6 III-3I18 che-1 I-3K15 F33D11.1 I-2P03
C28H8.9 III-3I19 cnd-1 III-2B18 F36F12.8 V-2C13
C29H12.5 II-4H10 D1046.2 IV-4F21 F38C2.8 IV-7J16
C33A11.4 X-7G15 D1081.2 I-4M01 F38H12.3 V-3D21
C33G8.10 V-5G01 daf-12 X-5M07 F41D3.3 I-6I21
C33G8.12 V-5G05 daf-12 X-5M11 F41H10.4 IV-2F20
C33G8.8 V-5E21 daf-14 IV-5M16 F42G2.6 II-2F13
C34B2.4 I-5K14 daf-16 I-5M24 F42H10.4 III-4D19
C34B7.4 I-4G21 daf-19 II-7M11 F44A2.4 V-6F13
C34D1.5 V-8D10 daf-3 X-1M03 F44C4.2 V-4H24
C36C5.13 V-2J04 dpl-1 II-6H13 F44E7.8 V-4M16
C36F7.1 I-4B02 dpy-20 IV-6A20 F45C12.15 II-2E19
C42D8.4 X-2N18 dpy-22 X-4H18 F45H11.1 I-5O01 
C44B9.4 III-5F02 dro-1 III-6J13 F47C10.1 V-3G04 
C44F1.2 III-1J24 eat-1 IV-4D11 F47C10.3 V-3G08
Table S3: List of screened transcription factor RNAi clones in ceh-2::YFP screen
          II-37
Gene Coordinates Gene Coordinates Gene Coordinates
F47C10.4 V-3G10 hlh-8 X-4M03 mls-2 X-2F16
F47C10.7 V-3G14 hnd-1 X-5J01 mxl-1 V-7N05
F47G9.4 V-7P21 K01H12.1 IV-5C17 mxl-2 III-1G23
F47H4.1 V-11J03 K03A11.5 X-6K11 mxl-3 X-6C16
F49E12.6 II-6K03 K04C1.2 X-6L15 ncl-1 III-4G07
F52C12.4 IV-1J05 K06A1.1 II-5A17 ngn-1 IV-8L18
F53B3.1 X-2A17 K06B9.5 IV-2K15 nhl-2 III-2F07
F53F8.1 V-13M01 K08F8.2 I-6I16 nhl-3 II-1E24
F53H1.4 IV-1O04 K11D2.4 I-6G22 nhr-1 X-7H18 
F53H4.5 X-7C06 let-381 I-3C19 nhr-10 III-3D10
F55A3.3 I-5O08 let-418 V-4O16 nhr-100 IV-5E01
F55A3.3 I-5O14 lim-4 X-2O04 nhr-103 V-2I13
F56F11.3 III-1J15 lim-7 I-2L05 nhr-104 IV-2B09
F56F3.4 III-2A24 lin-1 IV-1N03 nhr-105 IV-3O12
F57B10.1 I-3M11 lin-11 I-5K09 nhr-106 V-1M23
F59E11.10 V-6G14 lin-14 X-5B19 nhr-108 V-10F13
F59E11.11 V-6G16 lin-26 II-5B12 nhr-11 IV-4J17
fax-1 X-2K03 lin-29 II-8G07 nhr-111 V-10B16
fkh-10 I-5G15 lin-29 II-8G15 nhr-112 V-11O01
fkh-2 X-2K08 lin-31 II-3J21 nhr-113 I-5B18
fkh-3 & 4 X-6E18 lin-32 X-1D20 nhr-115 V-2M13
fkh-4 X-6E20 lin-35 I-2N15 nhr-116 V-11E14
fkh-5 III-2O14 lin-36 III-4A10 nhr-116 V-11E16
fkh-6 II-3F08 lin-39 III-4A21 nhr-118 V-3N21
fkh-7 IV-2L18 lin-41 I-4J11 nhr-119 II-2F08
fkh-7 IV-2L20 lin-42 II-1D18 nhr-119 II-2F12
fkh-8 II-4H24 lin-48 III-1J18 nhr-120 X-3D21
ham-2 X-2P09 lin-49 IV-4I16 nhr-121 III-1H19
hbl-1 X-3O03 lin-59 I-1H05 nhr-123 V-1M07
hif-1 V-13O05 lir-1 II-5B14 nhr-124 V-3I08
hlh-1 II-3J04 lir-2 II-5B16 nhr-125 V-3L07
hlh-10 V-6F01 lir-3 II-7N15 nhr-126 V-2K01
hlh-11 III-5K17 lpd-2 I-2P22 nhr-127 V-10J08
hlh-12 IV-4G20 ltd-1 II-5P20 nhr-128 V-2I15
hlh-13 X-2H09 M01E5.6 I-6B22 nhr-13 V-2G19
hlh-14 II-4J11 mab-18 X-5I17 nhr-13 V-2I03
hlh-15 X-1J06 mab-3 II-6P10 nhr-130 V-1O07
hlh-16 I-4I02 mab-5 III-4I09 nhr-132 V-1O13
hlh-17 IV-7J16 mab-9 II-1C14 nhr-134 V-2I09
hlh-19 X-1E19 mdl-1 X-3H11 nhr-135 V-5I11
hlh-2 I-3D23 mec-3 IV-5F05 nhr-136 V-8K07
hlh-21 III-1G09 med-1 X-5N14 nhr-137 X-3F05
hlh-25 II-4B13 mef-2 I-4D05 nhr-14 X-4G22
hlh-26 II-4B15 mes-6 IV-4I10 nhr-15 V-1G09
hlh-27 II-4B19 mes-6 IV-4I12 nhr-17 X-6C05
hlh-28 X-7H22 mgl-2 I-5O07 nhr-18 V-2I11
hlh-29 X-7J02 mix-1 II-7D13 nhr-19 II-6J12
hlh-3 II-6F03 mix-1 II-7D19 nhr-2 I-2N21
hlh-4 III-5O11 mls-1 III-4A01 nhr-21 II-5F23
hlh-6 II-6J18 mls-2 X-2F14 nhr-22 II-5A23
Table S3 continued: List of screened transcription factor RNAi clones in ceh-2::YFP screen
          II-38
Gene Coordinates Gene Coordinates Gene Coordinates
nhr-23 I-3F11 nhr-84 V-10B23 sop-3 I-8G11
nhr-25 X-6I19 nhr-85 I-6J15 sop-3 I-8G19
nhr-3 X-6D16 nhr-87 IV-8F19 sop-3 I-8G23
nhr-31 IV-4G11 nhr-88 II-2J14 sop-3 I-8I11 
nhr-35 X-2P13 nhr-88 II-2J16 sox-2 X-3L06
nhr-38 IV-5C21 nhr-88 II-2J20 sur-2 I-7G14
nhr-4 IV-5K05 nhr-89 I-6E04 T01D3.2 V-9C07
nhr-41 IV-1B01 nhr-9 III-3B02 T01G6.6 V-1O03
nhr-42 V-5E17 nhr-90 V-1E12 T03E6.3 V-11G23
nhr-43 IV-6G18 nhr-91 X-7E21 T04C10.4 X-6J22
nhr-44 V-6E18 nhr-91 X-7E23 T05C1.4 II-3H22
nhr-45 X-2D08 nhr-92 IV-8F23 T05G11.1 V-10F17
nhr-46 IV-2P24 nhr-94 V-5J01 T05G11.1 V-10F19
nhr-47 V-4C18 nhr-95 V-12I08 T06A10.4 IV-8E05
nhr-49 I-4N14 nhr-96 V-2K03 T08D10.1 X-5P15
nhr-50 V-10J23 nhr-97 IV-5E11 T09D3.4 V-4O03
nhr-51 V-10E18 nhr-98 V-1M09 T10B11.9 I-3M02
nhr-54 V-11E13 nob-1 III-6O01 T13C5.4 X-3I10
nhr-55 V-1O05 oma-2 V-5D12 T21B10.5 II-6O20 
nhr-56 V-2I17 osm-1 X-7M24 T22C8.5 II-6E08 
nhr-57 V-3F03 pal-1 III-2O04 T23B12.1 V-6C23
nhr-58 V-1O15 pax-3 II-7M03 T24H10.2 II-6F13
nhr-59 V-2M05 pes-1 IV-2H21 tab-1 II-5A12 
nhr-59 V-2M07 pha-4 V-13O01 taf-10 V-3D22
nhr-6 III-1F16 php-3 III-6M23 taf-11.2 I-3B21
nhr-60 V-10K18 pie-1 III-6E08 taf-3 X-7K02
nhr-61 II-9E18 pop-1 I-1K04 taf-4 I-1E17
nhr-62 I-4N02 pos-1 V-6A23 taf-5 I-3J16
nhr-62 I-4N04 R03E1.3 X-6J19 taf-6.1 II-1B18 
nhr-63 V-10J21 R04A9.5 X-1A23 taf-9 III-6D24
nhr-64 I-1M14 R05D11.1 I-4O23 tbp-1 III-3N22
nhr-65 V-12C18 R06C7.9 I-3H13 tbx-11 III-3O01
nhr-66 IV-4M05 R06F6.6 II-7D05 tbx-18 II-3K10 
nhr-67 IV-5P08 R07E5.3 III-2O05 tbx-2 III-2N13
nhr-68 V-7J14 R11G11.12 V-1A12 tbx-30 IV-8B10
nhr-69 I-4N18 R11H6.5 V-9H21 tbx-31 X-1F03
nhr-7 IV-6C03 R13D11.8 V-1B09 tbx-32 X-1D11 
nhr-70 V-12M01 ref-1 II-7O13 tbx-32 X-1D17
nhr-71 X-6O14 ref-2 X-4C05 tbx-33 III-6C21
nhr-72 II-3F13 rpm-1 V-6C14 tbx-33 III-6J06
nhr-74 I-5P17 sdc-1 X-7I12 tbx-35 II-4O24 
nhr-75 II-3H01 sdc-2 X-5D07 tbx-36 IV-6I18
nhr-76 IV-1A08 sdc-3 V-9F23 tbx-38 III-6G07
nhr-77 I-6A16 sel-8 III-1F20 tbx-41 X-1J15
nhr-78 IV-2O03 sem-4 I-3O02 tbx-8 III-5F01
nhr-8 IV-3J14 sex-1 X-5C07 tbx-9 III-5F09
nhr-80 III-1A07 skn-1 IV-2N18 tlf-1 I-4E14
nhr-81 I-6O05 sop-2 II-8A20 tlp-1 IV-7C16
nhr-82 I-6I17 sop-2 II-8E04 tra-1 III-5N20
nhr-83 V-1G08 sop-3 I-8E05 ttx-3 X-5L01
Table S3 continued: List of screened transcription factor RNAi clones in ceh-2::YFP screen
          II-39
Gene Coordinates Gene Coordinates
unc-115 X-5A09 ZK337.2 I-7M08 
unc-130 II-7B04 ZK381.5 IV-3M22
unc-3 X-6J06 ZK455.6 X-5O14
unc-3 X-6J10 ZK488.4 V-1E14
unc-30 IV-7A23 ZK697.2 V-1J06
unc-37 I-3E10 ZK856.9 V-7G21
unc-4 II-7E11 ZK945.5 II-7K13











































Table S3 continued: List of screened transcription factor RNAi clones in ceh-2::YFP screen
          II-40
Gene name Gene name Gene name Gene name Gene name Gene name
2L52.1 C07A12.1 C18B12.3 C33H5.17 C50E10.4 F16B12.6
AH6.5 C07A12.3 C18D1.1 C34B2.4 C50F4.12 F16B12.8
B0019.2 C07A12.5 C24G6.4 C34B7.1 C52B9.2 F16B4.9
B0035.1 C07E3.5 C24H11.3 C34C6.8 C53D5.4 F16H11.5
B0250.4 C07E3.6 C25A1.11 C34D1.1 C54C8.1 F16H9.2
B0261.1 C07H6.7 C25A1.2 C34D1.2 C54E10.5 F17A2.3
B0280.4 C08B11.3 C25B8.6 C34D1.5 C54F6.8 F17A2.5
B0280.8 C08C3.1 C25D7.3 C34E10.7 C54F6.9 F17A9.3
B0281.3 C08C3.3 C25E10.1 C34H3.2 C55B7.12 F17A9.6
B0286.5 C08F8.8 C25G4.4 C35C5.1 C56C10.8 F18A1.2
B0304.1 C08G9.2 C25H3.6 C35D10.16 C56E10.1 F18A1.3
B0310.2 C09F5.3 C26B2.3 C35D6.4 C56E10.4 F18A1.4
B0336.13 C09G12.1 C26B2.4 C36C5.13 D1005.3 F19B10.9
B0336.3 C09G4.5 C26C6.1 C36C9.2 D1007.1 F19B2.6
B0336.7 C09G9.6 C26C6.6 C36E8.1 D1014.8 F19F10.1
B0379.4a C09H10.6 C26D10.5 C36F7.1 D1046.2 F19F10.5
B0412.1 C09H6.1 C26E1.3 C37A2.5 D1081.2 F20D12.5
B0414.2 C10A4.8 C26E6.2 C37E2.4 D2030.7 F21A10.2
B0496.7 C10G8.6 C27A12.2 C37E2.5 DY3.3 F21D12.1
B0496.8 C10G8.7 C27A12.3 C37F5.1 E02H1.7 F21D12.5
B0564.10 C11G6.1 C27A12.5 C38D4.3 E02H9.8 F21D5.9
C01B12.2 C12C8.3 C27B7.4 C38D4.6 E03H4.13 F21G4.5
C01B7.1 C12D12.4 C27C12.2 C38D4.7 E03H4.6 F21H11.3
C01B7.6 C12D12.5 C27C12.6 C39E6.4 F01D4.6 F22A3.1
C01F1.1 C12D5.2 C27C7.3 C40H5.5 F01G10.8 F22A3.5
C01F6.9 C12D5.8 C27D6.4 C41G7.5 F01G4.1 F22D6.2
C01G12.1 C12D8.1 C28A5.4 C41G7.5 F02E9.4 F22E12.4
C01H6.5 C13C4.1 C28C12.8 C42D8.4 F08C6.7 F22F1.3
C02B4.2 C13C4.2 C28D4.1 C43H6.7 F09B12.2 F23A7.6
C02B8.4 C13C4.3 C28G1.4 C43H6.8 F09B9.2 F23B12.7
C02F12.5 C13G5.1 C28H8.6 C44B9.4 F09C6.8 F23C8.4
C02F5.12 C14B9.6 C28H8.9 C44C10.8 F09C6.9 F23F1.1
C03D6.5 C14C6.4 C29E6.5 C44F1.2 F09F3.10 F23F12.9
C03G6.10 C15H11.8 C29F7.4 C44H4.7 F09G2.9 F23H11.1
C03G6.12 C16A3.4 C29F7.5 C45E1.1 F10C1.5 F23H11.5
C03G6.8 C16A3.7 C29G2.5 C45E5.6 F11A1.1 F25D7.3
C04A2.3 C16C2.1 C29H12.5 C46E10.8 F11A1.3 F25E2.5
C04F1.3 C17A2.1 C30A5.7 C46E10.9 F11A10.2 F25E5.6
C04F5.5 C17A2.8 C32A3.1 C46F11.3 F11C1.6 F25H5.1
C04F5.9 C17C3.10 C32F10.2 C47C12.3 F13A2.8 F26A1.2
C04G2.7 C17C3.7 C32F10.5 C47F8.2 F13D11.2 F26A10.2
C05D10.1 C17C3.8 C32F10.6 C47F8.8 F13G11.1 F26B1.7
C05G6.1 C17E4.6 C33A11.4 C47G2.2 F13G3.1 F26C11.2
C05G6.2 C17E7.1 C33D12.1 C48D5.1 F13H6.1 F26D12.1
C06B8.1 C17E7.5 C33D3.1 C48E7.3 F14A5.1 F26F12.7
C06C6.4 C17E7.6 C33G8.10 C49C3.5 F14D12.2 F26F4.7
C06C6.5 C17E7.7 C33G8.12 C49D10.6 F14F3.1 F26F4.8
C06E1.8 C17E7.8 C33G8.6 C49D10.9 F14H3.11 F27D4.6
C06E2.1 C17H12.9 C33G8.8 C49F5.4 F15C11.1 F27E5.2
C06G3.1 C18A3.8 C33G8.9 C50B6.8 F15E6.1 F28B12.2
Table S4.  List of screened transcription factor RNAi clones in zmp-1::GFP screen
          II-41
Gene name Gene name Gene name Gene name Gene name Gene name
F28C6.1 F40G9.11 F47H4.1 F58A4.7 K10D3.3 R11E3.5
F28C6.2 F40G9.14 F48D6.3 F58E10.2 K10G6.1 R11G11.1
F28F5.3 F40G9.4 F48G7.11 F58E10.5 K10G6.3 R11G11.12
F28F9.1 F40H3.4 F48G7.3 F58E6.10 K11D2.4 R11G11.2
F28H6.2 F40H6.4 F49E10.5 F58H1.2 K11E4.5 R11H6.5
F29F11.5 F41B5.10 F49E12.6 F59B1.7 K11G9.4 R13.1
F29G9.4 F41B5.9 F49E8.2 F59B10.1 K11H12.8 R13.2
F30F8.8 F41D3.1 F49H12.1 F59E11.10 K12H4.1 R13A5.5
F31A3.2 F41D3.3 F52B5.5 F59E11.11 K12H6.1 R13D11.8
F31A3.4 F41H10.4 F52C12.4 H01A20.1 K12H6.12 R13F6.5
F31E3.2 F42A9.2 F52C12.5 H10E21.3 M01A10.1 R13H8.1
F31E8.3 F42G2.6 F52E1.1 H12C20.3 M01E11.5 R144.3
F31F4.12 F42G4.3 F52E10.1 H14A12.4 M01E5.6 R53.3
F31F6.1 F42H10.4 F52E4.8 H21P03.1 M02H5.3 R74.3
F31F7.3 F43D9.5 F52F12.4 H22D14.1 M02H5.6 T01B10.4
F32A5.1 F43G9.11 F53A2.5 H25P06.2 M02H5.7 T01C1.3
F32B6.1 F44A2.4 F53B2.6 H27C11.1 M03D4.4 T01D3.2
F32H2.1 F44A6.2 F53B3.1 K01G5.1 M04B2.1 T01E8.2
F33A8.3 F44B9.6 F53F8.1 K01H12.1 M04B2.3 T01G6.4
F33D11.1 F44C4.2 F53G12.5 K01H12.3 M04G12.4 T01G6.6
F33D4.1 F44C8.10 F53H1.4 K02B12.1 M05B5.5 T01G6.7
F33E11.1 F44C8.11 F53H4.5 K02B9.4 M106.1 T01G6.8
F33E11.2 F44C8.2 F54A5.1 K02C4.4 M142.4 T03E6.3
F33H1.1 F44C8.3 F54D1.4 K02F3.4 R02C2.4 T03F6.2
F33H1.4 F44C8.4 F54D5.11 K02F3.8 R02D1.1 T04C10.4
F34D10.5 F44C8.5 F54F2.5 K02G10.1 R02D3.7 T05A7.4
F35E8.12 F44C8.6 F54F2.9 K03A11.3 R02E12.4 T05B4.2
F35H8.3 F44C8.9 F54F7.1 K03A11.5 R03D7.4 T05C1.4
F36A4.14 F44D12.10 F55A3.3 K03B4.3 R03E1.3 T05G11.1
F36D1.1 F44E2.7 F55A3.7 K04C1.2 R03E9.1 T05G5.2
F36D3.2 F44E7.8 F55A8.1 K04C1.3 R04A9.5 T06A10.4
F36F12.8 F44G3.9 F55B11.4 K06A1.1 R04B5.3 T06C12.13
F37A4.8 F45C12.15 F55B12.1 K06A1.4 R05D11.1 T06C12.7
F37B4.10 F45E12.2 F55D12.3 K06B4.1 R05D11.1 T07C12.11
F37D6.6 F45E4.9 F55D12.4 K06B4.10 R05D3.3 T07C4.2
F37H8.1 F45E6.2 F55D12.4 K06B4.5 R06C7.9 T07C4.6
F38A5.13 F45H11.1 F56A12.1 K06B4.6 R06F6.6 T07D10.3
F38A6.1 F45H11.4 F56E3.4 K06B4.7 R07B1.1 T07F8.4
F38A6.3 F46C8.5 F56F11.3 K06B9.5 R07B7.13 T07G12.10
F38B7.1 F46F11.2 F56F3.1 K07C11.1 R07B7.14 T07G12.11
F38C2.2 F46G10.6 F56F3.4 K08A2.5 R07B7.15 T07G12.12
F38C2.5 F47A4.2 F56H1.2 K08A8.2 R07C12.4 T08D10.1
F38C2.7 F47C10.1 F57A10.5 K08B4.1 R07E5.3 T08G5.7
F38C2.8 F47C10.3 F57A8.1 K08B5.2 R07H5.10 T09A12.4
F38H12.3 F47C10.4 F57A8.5 K08E4.1 R08H2.9 T09D3.4
F39B2.4 F47C10.7 F57B10.1 K08F8.2 R09G11.2 T09F3.1
F39H11.2 F47D12.4 F57C12.3 K08F8.2 R10D12.2 T10B11.9
F39H11.3 F47E1.3 F57C9.4 K09H9.7 R10E11.1 T10D4.6
F40E10.2 F47F6.1 F57G4.6 K10C3.6 R10E4.11 T10G3.5
F40F8.7 F47G9.4 F57G8.6 K10D2.3 R119.6 T11A5.1
Table S4 continued.  List of screened transcription factor RNAi clones in zmp-1::GFP screen
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Gene name Gene name Gene name Gene name Gene name
T11B7.4 T27A8.2 Y16B4A.1 Y53G8AR.9 ZK1025.9
T12D8.7 T27B1.1 Y17D7A.1 Y53H1A.2 ZK1037.4
T12F5.4 T27B1.2 Y17D7A.3 Y54E10BR.8 ZK1037.5
T13C5.4 T27B7.1 Y17D7B.1 Y55F3AM.7 ZK112.2
T13F3.2 T27B7.2 Y17G7A.1 Y56A3A.18 ZK1128.4
T13F3.3 T27B7.3 Y18D10A.1 Y56A3A.28 ZK1193.5
T14F9.4 T27B7.4 Y1A5A.1 Y56A3A.4 ZK1240.1
T14F9.5 T27B7.5 Y22D7AL.16 Y57A10A.31 ZK1240.3
T14G12.4 T27C4.4 Y22F5A.1 Y57G11A.3 ZK177.10
T15D6.6 T27F2.4 Y32B12B.6 Y57G11C.25 ZK185.1
T15H9.3 T28D9.9 Y37E11B.1 Y59E9AR.3 ZK218.6
T16H12.4 T28F12.2 Y37E11B.2 Y5F2A.4 ZK265.4
T18D3.7 T28H11.4 Y38E10A.1 Y5H2B.2 ZK337.2
T19A5.4 VC5.5 Y38E10A.6 Y60A9.3 ZK370.2
T19A5.5 W01D2.2 Y38F2AR.13 Y62E10A.17 ZK380.1
T19B10.11 W02A2.7 Y38H8A.5 Y65B4A.7 ZK381.5
T19E7.2 W02C12.3 Y39A1C.3 Y66A7A.5 ZK418.1
T19H12.8 W02D3.9 Y39A3CR.6 Y66A7A.8 ZK418.9
T20B12.2 W02D7.6 Y39B6A.12 Y67A6A.2 ZK455.6
T20B12.6 W02D9.3 Y39B6A.17 Y67A6A.2 ZK488.1
T20B12.8 W02H5.7 Y39B6A.36 Y67D8A.3 ZK488.2
T20F7.1 W03A3.1 Y39B6A.47 Y69A2AR.26 ZK488.4
T20H4.2 W03C9.4 Y40B1A.4 Y69A2AR.29 ZK6.1
T21B10.5 W03D2.1 Y41D4B.7 Y6G8.3 ZK6.2
T22B3.1 W03F9.2 Y41D4B.8 Y70C5C.6 ZK6.5
T22B7.1 W04A8.7 Y43F8C.10 Y71F9B.10 ZK652.5
T22C8.3 W04D2.4 Y44E3B.1 Y71H2AM.17 ZK652.6
T22C8.4 W04H10.3 Y46H3D.6 Y75B8A.1 ZK682.4
T22C8.5 W05B5.3 Y47D3A.6 Y75B8A.2 ZK697.2
T22E7.2 W05E10.3 Y47D3B.7 Y75B8A.29 ZK829.5
T22H6.6 W05H7.4 Y47D3B.9 Y75B8A.6 ZK856.13
T23B12.1 W06H12.1 Y48A6C.1 Y77E11A_3443.a ZK856.9
T23G4.1 W09B6.2 Y48A6C.3 Y77E11A.6 ZK892.7
T23G5.6 W09C2.1 Y48A6C.5 Y80D3A.3 ZK909.4
T23G7.1 W10C8.2 Y48B6A.14 Y82E9BR.1 ZK945.5
T23H4.2 W10D5.1 Y48G8AR.1 Y82E9BR.15 ZK993.1
T24A6.8 W10D5.3 Y48G9A.11 Y95B8A.7
T24B8.6 Y104H12A.1 Y49E10.14 ZC123.3
T24C4.7 Y105E8A.17 Y51A2D.17 ZC132.2
T24D3.1 Y105E8C.s Y51B9A.5 ZC204.2
T24H10.1 Y106G6H.4 Y51H1A.5 ZC247.3
T24H10.2 Y113G7B.14 Y51H4A.12 ZC328.2
T25C12.1 Y116A8C.17 Y51H4A.17 ZC376.4
T26A5.8 Y116A8C.18 Y51H4A.4 ZC395.8
T26A8.4 Y116A8C.20 Y53C10A.12 ZC410.1
T26C11.1 Y116A8C.22 Y53C10A.3 ZC416.1
T26C11.5 Y116A8C.35 Y53C12B.5a ZC513.6
T26C11.6 Y11D7A.12 Y53C12C.1 ZC64.3
T26E4.8 Y11D7A.13 Y53F4B.3 ZC64.4
T27A1.6 Y15E3A.1 Y53F4B.5 ZC8.4
Table S4 continued.  List of screened transcription factor RNAi clones in zmp-1::GFP screen
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The Caenorhabditis elegans vulva is an elegant model for dissect-
ing a gene regulatory network (GRN) that directs postembryonic
organogenesis. The mature vulva comprises seven cell types (vulA,
vulB1, vulB2, vulC, vulD, vulE, and vulF), each with its own unique
pattern of spatial and temporal gene expression. The mechanisms
that specify these cell types in a precise spatial pattern are not well
understood. Using reverse genetic screens, we identified novel
components of the vulval GRN, including nhr-113 in vulA. Several
transcription factors (lin-11, lin-29, cog-1, egl-38, and nhr-67) in-
teract with each other and act in concert to regulate target gene
expression in the diverse vulval cell types. For example, egl-38
(Pax2/5/8) stabilizes the vulF fate by positively regulating vulF
characteristics and by inhibiting characteristics associated with the
neighboring vulE cells. nhr-67 and egl-38 regulate cog-1, helping
restrict its expression to vulE. Computational approaches have
been successfully used to identify functional cis-regulatory motifs
in the zmp-1 (zinc metalloproteinase) promoter. These results
provide an overview of the regulatory network architecture for
each vulval cell type.
genetic regulatory networks  nematode  transcriptional regulation
Complex interactions of signaling molecules, transcriptionfactors, and effector genes direct spatial and temporal
patterning during organogenesis (1). The differentiation and
morphogenesis of the Caenorhabditis elegans vulva is useful for
studying the gene regulatory network (GRN) of larval stage
organogenesis due to its invariant cell lineage, its amenability to
genetic manipulation, and the availability of reporter genes with
many spatial and temporal expression patterns in the seven
vulval cell types (2). In ref. 3, we described a regulatory network
of interactions between a set of evolutionarily conserved tran-
scription factors and an array of genes expressed in the differ-
entiated cells of the C. elegans vulva. Here, we briefly review
vulval development and aspects of the provisional GRN direct-
ing its organogenesis. We then describe additional pairwise
trans-regulatory interactions, including the results of RNAi
screens and a cis regulatory analysis of zmp-1 that together help
refine our network model, and infer common network themes,
such as boundary formation, combinatorial control, and stable
feedback loops. These additional data support the hypothesis
that overall network architecture is unique for each of the vulval
cell types.
The life cycle of C. elegans consists of four larval stages (L1–4)
and an adult stage, with each stage separated by a molt (2). The
C. elegans vulva is derived postembryonically from six vulval
precursor cells (VPCs) termed P3.p-P8.p. All VPCs are com-
petent to receive an inductive signal from a specialized somatic
gonadal cell, the anchor cell (AC), during the L2 stage. P6.p,
which is closest to the AC, is induced to generate the 1° vulval
lineage, producing the inner cells of the vulva. The P5.p and P7.p
cells generate 2° vulval lineages, producing the outer cells of the
vulva. P3.p, P4.p, and P8.p are uninduced and adopt the 3° fate,
and fuse to the hypodermal syncytium hyp7. The L4 stage vulva
comprises 22 differentiated cells that are descendents of P5.p,
P6.p, and P7.p, and that are of seven different types: vulA, vulB1,
vulB2, vulC, vulD, vulE, and vulF [supporting information (SI)
Fig. S1]. EGF, Notch, and Wnt signaling pathways specify which
VPCs generate the 1° and 2° lineages, but we are just now
identifying the network of transcription factors that control
cell-fate differentiation in the seven vulval cell types (2).
The C. elegans vulva allows passage of sperm and eggs by
connecting the uterus to the outside environment (2). Each
vulval cell type has specialized roles that contribute to vulval
function andmorphology. For example, vulF cells, the innermost
vulval cells, contact the AC and the uterus; they are the target
for AC invasion, thus creating the vulval-uterine connection
required for egg-laying (4). Vulval muscles that regulate egg-
laying connect to the vulva between vulC and vulD, and the
outermost portion of the vulva comprises the vulA cells, which
attach the vulva to the hypodermis (2). The unique patterns of
gene expression in each of the vulval cell types are likely
responsible for their individual properties. Comparison of the
vulval GRN to those in other organisms is necessary for expand-
ing our knowledge of organ development.
Results and Discussion
Functional Roles of Gene Expression During Vulval Differentiation.
Much is known about the signaling network that establishes the
pattern of vulval cell differentiation, but our understanding of
the GRN that specifies the terminal seven vulval cell types is
limited (2). Five transcription factors (lin-11, lin-29, cog-1, egl-38,
and nhr-67) are major regulators of cell-fate determination and
morphogenesis in the vulva. lin-11 encodes a LIM homeodomain
protein, consisting of a homeodomain and two specialized
LIM-type zinc-fingers (5). LIM homeodomain family members
play roles in differentiation and pattern formation in arthropods
and vertebrates (6, 7). lin-29, a C2H2-type zinc finger, plays a
role in many events occurring at the larva to adult transition,
including terminal differentiation of the seam cells (8), morpho-
genesis (9), and formation of the vulval-uterine-seam cell con-
nection (10). cog-1 encodes a Nkx6.1/6.2 homeoprotein tran-
scription factor (11); vertebrate Nkx6.1 proteins are involved in
neuronal and pancreatic endocrine cell formation (12, 13). egl-38
encodes a Pax2/5/8 protein, which are known to be involved in
organogenesis; e.g., mouse Pax2 mediates nephrogenesis (14,
15). nhr-67 is an ortholog of Drosophila melanogaster tailless (tll)
(16), a conserved nuclear hormone receptor necessary for
Drosophila embryogenesis and neuronal development (17). The
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pattern of vulval cell types is specified by the differential
interactions of the transcription factors that operate within each
cell (2).
We have identified 30 genes dynamically expressed in specific
subsets of the cells of the mature C. elegans vulva (Table S1 has
a complete list). These genes encode transcription factors,
guidance cues, proteases, structural proteins, signaling mole-
cules, and novel proteins with unknown function. The physio-
logical relevance is known for several genes. For example, egl-17,
which encodes a fibroblast growth factor (FGF), is necessary for
migration of the sex myoblasts to the vulva (18). Induction of the
uterine uv1 cells depends on the epidermal growth factor (EGF)
family member lin-3 (19). bam-2 (neurexin-related transmem-
brane protein) and syg-2 (transmembrane Ig superfamily pro-
tein) are required for vulval innervation (20, 21). sqv-4, which
encodes an UDP-glucose dehydrogenase-related protein, is in-
volved in the structural integrity and morphology of the vulva
(22). The significance of some of the genes expressed in the vulva
is not yet known, including the Drosophila empty spiracles (ems)
homolog ceh-2 (23), a cadherin-related protein encoded by cdh-3
(24), and zmp-1, which encodes a MT4-MMP-related zinc me-
talloproteinase (23, 25). Genetic perturbations that result in
altered expression patterns of these effector genes are helpful in
elucidating the regulatory network.
Several additional genes with detectable expression in the
mature vulva, including two putative transcription factors, have
been identified since we last described the vulval GRN (3). The
Pax2/5/8 gene pax-2 is expressed exclusively in the vulD cells (16).
pax-2 is the result of a recent duplication of egl-38 (26). egl-38 has
been identified as a regulator of cell-fate specification in the C.
elegans vulva (3, 15, 19). lin-39 encodes a Hox protein that is an
ortholog of Drosophila Sex combs reduced (Scr) (27, 28). During
the late L3 stage, lin-39 expression increases in the vulA pre-
cursor cells; this expression persists in vulA until late L4 (29).
The Patched-related protein DAF-6 is expressed in vulE and
vulF (30). Hao et al. (31) reported the expression of seven
hedgehog-related genes in the vulva: grd-5 in vulB and vulD,
grd-12 in vulC, grl-4 in vulA and vulB, grl-10 in vulA and vulB,
grl-15 in vulB, vulC, vulD and vulE, grl-25 in vulA, and grl-31 in
vulF. Last, nas-37 (32), which encodes a metalloprotease, is
expressed in vulB (data not shown).
Conserved Regulatory Strategies in the Vulval GRN. In ref. 3, we
described how the expression patterns of a subset of reporter
constructs are affected in transcription factor mutant back-
grounds. We have increased the number of known interactions
more than twofold, from 15 to 36, and identified many of the
regulatory relationships among the transcription factors (Table
1, Fig. S2, and Table S2). This network includes strategies that
are shared by other GRNs. For example, the cell-type specific
expression of cog-1 appears to be restricted to the vulC and vulD
cells by a variety of mutual and autoregulatory controls (16). In
a second example, lin-11 is necessary for vulA-specific expression
of nhr-67 (16). In turn, nhr-67 is necessary for the expression of
the vulA effector gene zmp-1. The differentiated state of vulA
may be further stabilized, because nhr-67 is positively autoregu-
lated in vulA. This is an instance where multiple positive inputs,
including feedback loops, ensure the maintenance of a terminal
cell fate.
Other network strategies that are present in the vulva include
combinatorial control circuits. egl-17 expression in vulF is perturbed
by neither cog-1 nor egl-38mutations (16). However, egl-17 expres-
sion is derepressed in vulF in cog-1; egl-38 double mutants. This
redundancy could ensure proper execution of cell fate. Finally,
negative autoregulation, as in cog-1 in vulA, vulB, vulE, and vulF
and nhr-67 in vulC, vulD, vulE, and vulF, appears to be a funda-
mental strategy used in the vulval GRN (16). Negative autoregu-
lation has been found to accelerate gene circuit response time and
assists in making quick cell fate decisions (33).
LIN-29 and LIN-11 Interact to Determine Vulval Cell Fate. By exam-
ining the effects of specific transcription factor mutations on a
wider array of genes expressed in the mature vulva, we have
found increased complexity in some of their roles. We had
hypothesized that lin-29 is a temporal regulator of gene expres-
sion, because it is required for vulval gene expression at the mid
to late L4 stage (egl-17 in vulC and vulD, ceh-2 in vulC, and zmp-1
in vulD and vulE) (3, 23), and functions in several developmental
processes at the L4 stage to adult transition (8–10, 34). However,
in a lin-29 mutant background the mid-L4 expression of lin-3 in
vulF cells is not abolished, whereas expression of dhs-31, which
is initiated in gravid adults, is abolished (Table 1 and Fig. S2).
LIN-29 is necessary for wild-type levels of lin-11 transgene
expression (Table 1) and is thus a key regulator of lin-11. In
addition to genes described in ref. 3, lin-11 is required for dhs-31,
egl-26, lin-3 and pepm-1 expression (Table 1). Thus, of the known
vulval transcriptional regulators, lin-11 exhibits the broadest
effect (3). egl-17 during L3 and cdh-3 in vulF are the only vulva
Table 1. Expression of dhs-31, egl-26, lin-3, lin-11, pepm-1 and unc-53 in the vulva.
Reporter Mutation vulA vulB1 vulB2 vulC vulD vulE vulF n
dhs-31  0 100 100 0 100 0 0 31
dhs-31 lin-11(n389) 0 0* 0* 0 0* 0 0 28
dhs-31 lin-29(sy292) 0 0* 0* 0 0* 0 0 42
egl-26  0 61 30 0 61 30 0 37
egl-26 lin-11(n389) 0 0* 1* 0 0* 1* 0 39
lin-3  0 0 0 0 0 0 98 26
lin-3 lin-11(n389) 0 0 0 0 0 0 7* 22
lin-3 lin-29(n333) 0 0 0 0 0 0 81 18
lin-11  41 92 90 81 100 0 0 38
lin-11 lin-29(sy292) 5* 43* 59† 30* 58* 0 0 52
pepm-1  0 0 0 91 91 95 95 22
pepm-1 lin-11(n389) 0 0 0 0* 0* 0* 0* 50
pepm-1 lin-29(sy292) 0‡ 0‡ 0‡ 67‡ 67‡ 67‡ 67‡ 55
unc-53  0 0 0 100 0 0 0 Many
unc-53 lin-29(sy292) 0 0 0 80 0 0 0 20
Percentages of cells that expressdhs-31::YFP, egl-26::GFP, lin-3::GFP, lin-11::GFP,pepm-1::GFP andunc-53::GFP.
Boldface indicates P values are significantly different than wild type. *, P  0.000; †, P  0.002.
‡pepm-1::GFP is not detectable until the end of the fourth larval stage, at which point the vulva has already
protruded in lin-29(sy292) mutants, making it difficult to distinguish between the vulval cell types.
20096  www.pnas.orgcgidoi10.1073pnas.0806377105 Ririe et al.
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expression patterns not abolished in a lin-11 background. Re-
porter constructs are powerful tools for identifying genes’ spatial
and temporal expression patterns; however, reporter gene con-
structs might well lack relevant regulatory motifs. Consequently,
we might be missing some regulatory connections.
The interplay between lin-11, lin-29 and their downstream
targets is complex. lin-11::GFP expression is not abolished in a
lin-29 mutant background, and several of the gene expression
patterns perturbed by loss of lin-11 are not affected in a lin-29
deficient background (Fig. S2). LIN-29 might act in concert with
another, as yet unidentified, factor to ensure the proper tem-
poral and spatial expression of the general cell-fate regulator
LIN-11. Considering LIN-29’s role as a regulator of develop-
mental timing, it could serve as a temporal input, whereas
another factor serves as the spatial input.
Identification of Additional Components of the Vulval GRN. Tran-
scription factors identified by forward genetic screens are biased
by ascertainment toward those with strong, nonredundant ef-
fects, and those that affect multiple aspects of vulval develop-
ment. Two categories of transcription factors are relatively more
difficult to identify in genetic screens. Mutations that result in
lethality or other severe defects will not be identified for roles
that a partial loss of function mutation might reveal in postem-
bryonic development. Conversely, genes with more subtle de-
velopmental phenotypes are also more likely to be overlooked.
We identified genes in both these categories by RNA interfer-
ence (RNAi) screens of 508 transcription factors (Table S3). One
of these screens was conducted in a ceh-2::YFP background, a
readout for vulB fate during the L4 stage, and identified nhr-67
(tailless) (16). Because nhr-67 deletion mutants die as young
larvae, its role in vulval development was not identified. RNAi
often causes a partial-loss-of-function phenotype instead of a
null phenotype. It can also serve as a temporal or conditional
downregulator of gene function. In the case of nhr-67, the larval
lethality phenotype was bypassed, because RNAi was adminis-
tered to L1 larvae, thus making its vulval phenotypes visible.
The second screen was conducted in a zmp-1::GFP back-
ground, focusing on perturbations of vulA expression. This
screen also identified nhr-67, and the orphan nuclear hormone
receptor nhr-113 as positive regulators of zmp-1 expression in
vulA cells. nhr-113 might have a narrow role in vulval organo-
genesis, because nhr-113 RNAi has no effect on the regulation
of several other genes: cdh-3, ceh-2, dhs-31, lin-3, or pepm-1 (data
not shown). These results, however, show that RNAi screens can
identify new components of GRNs.
Differentiation of Discrete Fates in the 1° Vulval Lineage. The 1°
lineage of the vulva generates four vulE and four vulF cells.
Signals from the AC and Wnt are required for proper specifi-
cation of these cell fates (25). The GRN, however, which acts
downstream of these intercellular signals to guide differentiation
of vulE and vulF fates, is not known. egl-38::GFP is detectable
solely in the vulF cells (35); however, analysis of the mutant
egl-38 with nhr-67 RNAi and mutant cog-1 shows that egl-38
functions in vulF cells and inhibits both ceh-2 and egl-17 expres-
sion in vulE (16) and vulF (3). Consequently, egl-38, cog-1, and
nhr-67 enforce spatial boundaries by preventing the 2° cell-fate
associated genes ceh-2 and egl-17 from being expressed in 1° cells
(Fig. S2, vulE and vulF).
It was speculated that the vulF cells, which are nearer the AC,
have higher levels of nhr-67 activity versus cog-1, whereas vulE
cells have higher levels of cog-1 than nhr-67 (16). The recent
availability of an egl-38::GFP reporter has allowed us to dissect
further the GRN controlling the vulE versus vulF fates. egl-38
expression in the vulF cells is positively regulated by nhr-67 (Fig.
1). This egl-38 expression is necessary for specification of the uv1
fate via regulation of the vulF specific gene lin-3, thus allowing
for the proper development of a vulval-uterine connection (19).
Conversely, zmp-1 is expressed in vulE but not vulF, and egl-38
is required for inhibiting zmp-1 expression in the vulF cells (3).
In vulE cells, where egl-38 expression is absent, lin-3 is not
expressed and cog-1 activated expression of zmp-1 is observed
(19). egl-38 expression is unaffected in a cog-1(sy275) back-
ground, but in an egl-38(n578) background egl-38::GFP expres-
sion is decreased, suggesting that egl-38 positively autoregulates
in vulF (Fig. 1). Therefore, egl-38 appears to stabilize vulF fate
by repressing vulE characteristics and by reinforcing its own
expression (Fig. 2).
In the vulE and vulF cells, cog-1 and nhr-67 negatively regulate




Fig. 1. egl-38 expression in the vulF cells is dependent on several regulatory
inputs. (A–C) Nomarski (Left), fluorescence (Center) and overlaid (Right). All
animals displayed carry the egl-38::GFP [guEx877] transgene in their back-
ground. (A) In wild-type animals, egl-38 is detected exclusively in the vulF cells
(arrows). (B) nhr-67 RNAi results in the abolition of egl-38 expression in the
vulF cells (arrows). (C) egl-38(n578) mutants lose the ability to positively
autoregulate their expression levels in vulF (arrows).
Fig. 2. Differentiation of vulE vs. vulF. The positions of the vulE and vulF cells
relative to the anchor cell (AC) are shown. vulF is closer spatially than vulE to
the AC. The network diagram was generated using BioTapestry Editor, Ver-
sion 2.1.0 (www.biotapestry.org) (44). Linkages with arrowheads represent
positive inputs and linkages with bar-heads represent repressor inputs for
target gene expression. Black font indicates detectable expression levels and
gray font indicates no detectable expression. This model presumes thatnhr-67
acts in the AC to differentiate between vulE and vulF cells. Signal X could be
Ras, Wnt, or some other signaling pathway. The blue linkage in vulF is
indicated by a thicker line than the blue linkage in vulE because it is hypoth-
esized that vulF receives higher levels of signal X-mediated nhr-67 signal from
the AC. The thick purple and pink linkages highlight differences in the
network architecture between the vulE and vulF cells, respectively.
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might allow 1° cells to rapidly switch their fates upon altered
intra- and intercellular inputs. Presumptive vulE cells can induce
uterine uv1 fate specification in the absence of vulF cells, thus
ensuring the establishment of a proper vulval-uterine connection
(19). These observations fit a model in which presumptive vulE
and vulF cells are bipotential and positional cues help specify
their fates. In this model, vulE, would then be biased for
increased nhr-67 activity in the absence of vulF. egl-38 levels
would thus increase, and vulF characteristics would be activated,
whereas vulE characteristics would be inhibited.
Dissection of zmp-1 Regulatory Elements. The vulA cells occupy a
unique position as they form the outermost ring of cells and fuse
to the surrounding hypodermal syncytium. zmp-1 (zinc metal-
loproteinase) is first expressed in vulD and vulE cells beginning
at the late L4 stage and in the vulA cells at the L4 to adult
transition (23). vulA-specific expression of zmp-1 is initiated in
a different temporal window than its expression in vulD and
vulE, which is particularly interesting because, in a lin-29 back-
ground, vulD and vulE expression is abolished, but vulA expres-
sion is unaffected. Because lin-29 affects early zmp-1 expression
(vulD and vulE) but not late expression (vulA), and because
lin-29 temporally regulates gene expression, it seems likely that
modular cis-regulatory elements drive zmp-1 expression.
A 386-bp fragment of upstream sequence (mk50–51) is suf-
ficient to drive vulA- and vulE- but not vulD-specific expression
of zmp-1 (36). We analyzed sequences upstream of zmp-1
and its orthologs in C. briggsae (CBG09053) and C. remanei
(CRE04503), using Cistematic (37), which carries out motif-
finding and phylogenetic footprinting (Table 2 and Fig. S3) and
identified three motifs within the mk50–51 zmp-1 enhancer
element and a fourth motif five basepairs upstream of the 5 end.
We deleted the instances of the motifs and analyzed their effects
on zmp-1 reporter expression. Deletion of element 103/4 de-
creased vulA expression and abolished vulE expression. Previous
cis-regulatory studies did not identify an element competent to
drive vulA expression in the absence of vulE. Deletion of
element 107/8 decreased vulA and vulE expression. Deletion of
element 105/6, however, resulted in ectopic expression of
mk50–51 zmp-1::GFP in vulC, vulD, and vulF. Thus, these
elements likely act as positive (103/4 and 107/8) and negative
(105/6) regulatory sites for controlling of zmp-1 expression.
Conclusion
The regulatory architecture of the vulval GRN differs in all seven
cell types. We postulate that this accounts for the differences in
vulval cell fate, function, and morphology. Development of the
C. elegans vulva utilizes several types of gene regulatory strate-
gies that have been identified in other networks. For example,
COG-1 participates in a network of mutual inhibitions with
NHR-67 in the 1°-lineage derived vulval cells to differentiate
between the vulE and vulF fates. This is reminiscent of the
cross-inhibitory interaction of COG-1 and DIE-1 in the C.
elegans ASE neurons (38). Vertebrate COG-1 homologs, the
homeodomain proteins Nkx6.1 and Nkx6.2, might act in a similar
manner (3). These proteins interact with the transcription factors
Dbx1 and Dbx2 in a network of mutual inhibitions to specify
motor neuron and interneuron fates during neural tube devel-
opment (13). In another example, lin-11 function is necessary for
EGL-17 (FGF) expression in the vulva. An analogous network
interaction is present during heart development in mice. Isl1,
which like lin-11 is a LIM homeodomain transcription factor, is
required for the expression of FGFs (39).
We also describe new interactions within the vulva that may
aid in the understanding of analogous regulatory interactions in
other transcriptional networks, because the majority of the
transcription factors and effectors present in this GRN have
relatives in a diverse array of organisms. These interactions
include positive regulation of lin-11 by the heterochronic tran-
scription factor LIN-29, lin-3 (EGF) by LIN-11, and egl-38
(Pax2/5/8) by NHR-67 (tailless). Our increased knowledge of the
roles of transcription factors, such as lin-11 (LIM homeodomain)
and egl-38 (Pax2/5/8) may help to further characterize other
GRNs. For example, a LIM homeodomain protein (Lim1) and
a Pax2/5/8 protein (Pax2) are involved in murine kidney devel-
opment (40). Thus, the GRN that directs nephrogenesis in mice
appears to share at least two components with the vulval network
in C. elegans. Our understanding of the kidney morphogenesis
GRN in mammals may be enhanced by investigating the mouse
orthologs of other components of the vulval GRN.
New approaches are needed to elucidate all of the constituents
of the complex regulatory architecture that directs organogen-
esis. Until now, most of the key players in vulval organogenesis
have been isolated using traditional mutagenesis screens. These
types of screens, however, are often limited to identifying only
those factors with severe phenotypes. To account for the regu-
lation of all genes that are expressed and function during vulva
development it is apparent that other members of the vulval
GRN are yet to be identified. There are transcription factors with
major and minor effects. For example, LIN-11 is required in two
tissues for egg-laying and regulates gene expression in multiple
vulval cell types. By contrast, using an RNAi screen we were able
to identify NHR-113, a factor that is possibly only required for
fine tuning gene expression in the vulA cells.
Analysis of the effects of various genetic perturbations on
vulval organogenesis has revealed detailed spatial and temporal
distinctions in the regulation of diverse yet related cell types. Our
approach provides for precise and accurate study of gene
expression in an intact organism and unveils the distinct network
architecture in the different cell types. Further dissection of the
genomic network within the differentiated cell types would
extend our knowledge of vulval organogenesis and could also
provide further insights into organogenesis in other systems.
Materials and Methods
Genetics and RNAi. C. elegans strains were grown and constructed using
standard protocols. Thenhr-67RNAi feeding protocol was described in ref. 16.
Generation of Reporter Transgenes. syEx1009, syEx1091 and syEx1018 were
generated by deleting one motif each, 103/4 (5-CGAGTACGTTTACAC-3),
105/6 (5-GTACGTATTGCTT-3), or 107/8 (5-AGAAAAAGTAGAAGG-3), re-
spectively, from the mk50–51 (36) construct and replacing the motif with a
SacII restriction site. These constructs were then individually injected into the
gonads of unc-119(ed4); him-5(e1490) animals (41), using unc-119() (42) and
pBSK (Stratagene). syEx756 and syEx1012 were generated by injecting the
constructs pNP10 (43) and mk50–51 (36), respectively, into a unc-119(ed4);
him-5(e1490) background.
Microscopy. 3 mM levamisole was used to anesthetize transgenic animals for
observation using Nomarski DIC optics.
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The vulval development of Caenorhabditis elegans provides an
opportunity to investigate genetic networks that control gene
expression during organogenesis. During the fourth larval stage
(L4), seven vulval cell types are produced, each of which executes
a distinct gene expression program. We analyze how the expres-
sion of cell-type-specific genes is regulated. Ras and Wnt signaling
pathways play major roles in generating the spatial pattern of cell
types and regulate gene expression through a network of tran-
scription factors. One transcription factor (lin-29) primarily controls
the temporal expression pattern. Other transcription factors (lin-
11, cog-1, and egl-38) act in combination to control cell-type-
specific gene expression. The complexity of the network arises in
part because of the dynamic nature of gene expression, in part
because of the presence of seven cell types, and also because there
are multiple regulatory paths for gene expression within each cell
type.
organogenesis  signaling pathways  transcription
Developmental events are driven by spatially and temporallyregulated gene expression. Understanding how complex
patterns of expression are produced is therefore a critical part of
deciphering mechanisms of development. In general, intercel-
lular signaling mechanisms interact with a network of transcrip-
tion factors to generate cell-type-specific patterns of gene ex-
pression. The late stage of Caenorhabditis elegans vulval
development offers a useful model in which to study this process.
During this period of vulval development, seven distinct cell
types are produced that express unique combinations of genes.
Over the last several years, a number of genes were discovered
that are expressed in cell-type and stage-specific patterns in the
vulva, and several transcription factors were found to regulate
these genes. In this paper, we synthesize and extend our current
knowledge of this genetic network.
TheC. elegans vulva connects the uterine lumen to the outside,
allowing for passage of sperm and fertilized eggs (1). Vulval cells
are generated postembryonically from precursor cells P3.p P4.p,
P5.p, P6.p, P7.p, and P8.p [also called vulval precursor cells
(VPC)]. During the mid-third larval (L3) stage, EGF and Notch
signaling induces the middle three VPCs (P5.p, P6.p, and P7.p)
to adopt vulval fates, whereas P3.p, P4.p, and P8.p fuse with the
hypodermal syncytium, hyp7 (2–6).
During the late-L3 to the early-L4 stage, P5.p, P6.p, and P7.p
undergo two or three rounds of cell division to produce 22 nuclei
(7) (Fig. 1A). These nuclei are in cells of seven types (vulA,
vulB1, vulB2, vulC, vulD, vulE, and vulF), as evidenced by
subsequent morphogenetic movements and by the pattern of
gene expression (8, 9) (Fig. 1B). The seven cell types that are
present in the adult vulva represent specializations within the
general epithelial cell class. These cells exhibit cell-type general
features; for example, each expresses ajm-1, a component of the
apical junction that connects neighboring cells in epithelial
tissues (8). However, in addition, each cell type exhibits func-
tional specializations: vulF cells, which form the innermost
section of the vulva, connect directly with cells of the uterus. vulE
cells form structural attachments to lateral hypodermal (seam)
cells. vulC and vulD cells attach to vulval muscles that open the
vulva for the passage of eggs. vulA cells form attachment to the
hyp7 syncytium. It is expected that gene expression differences
underlie these specializations.
Here, we are concerned with the execution of cell-type-
specific gene expression programs during the late L3 and L4
stages, mostly after the terminal division of vulval cells. During
this period, each cell type exhibits a cell-type-specific pattern of
gene expression, and several transcription factors are known that
regulate the expression of these cell-type-specific genes. We
bring together our current knowledge of this system to produce
the framework in which to investigate the gene regulatory
network controlling vulval organogenesis.
Materials and Methods
Determination of Gene Expression Patterns. Essentially all gene
expression analyses described in this paper (including data from
other papers) were carried out by using gfp reporter transgenes.
For all results, it is possible that reporter expression does not
accurately reflect the expression pattern of the endogenous
gene. For simplicity, we refer to the reporter by the correspond-
ing gene name.
The expression pattern of C55C3.5 was determined by using
gfp reporter clone pUL#G221N (I. Hope, personal communi-
cation). This plasmid was injected into unc-119(ed4) animals by
using the plasmid pDP#MM016B [unc-119()] as a coinjection
marker (10). Of genes listed in Fig. 1B and in the main text, we
have not examined the expression pattern of syg-2, bam-2, and
sqv-4. Because GFP is likely to be stable for many hours, the time
at which expression is turned off is not reliably indicated by
decreased GFP expression. For most genes we analyzed, GFP
fluorescence persists into the adult stage.
Genotypes. For Tables 1–3, gfp reporter transgenes used were
ayIs4[egl-17::gfp], syIs50[cdh-3::gfp], syIs49[zmp-1::gfp], and
syIs54[ceh-2::gfp] (9). The egl-26::gfp transgenic line analyzed
was kuIs36 (11). Mutations used are; cog-1(sy275), cog-1(sy607),
lin-29(sy292), lin-11(n389), and egl-38(n578). Of two cog-1 tran-
scripts, the longer cog-1A transcript contains a corepressor-
binding domain, whereas the shorter cog-1B transcript does not
(12). sy275 is a missense mutation predicted to affect both
transcripts. sy607 is a deletion that eliminates the cog-1A tran-
script. The two alleles exhibit complementary defects in vulval
development (13). Although both alleles are recessive, it is not
known whether the loss of cog-1 function causes observed
phenotypes. lin-29(sy292) and lin-11(n389) are strong loss-of-
function alleles, and egl-38(n578) is a reduction-of-function
allele. Strains were constructed by using standard methods.
Results and Discussion
Vulval Cell-Type-Specific Gene Expression. A number of genes are
expressed in specific subsets of vulval cells (Fig. 1B). Previously
This paper was submitted directly (Track II) to the PNAS office.
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described genes of this type include cdh-3 (14), egl-17 (15), lin-3
(16), zmp-1 (9, 17), ceh-2 (9), T04B2.6 (9), F47B8.6 (9), B0034.1
(9), unc-53 (18), egl-26 (11), sqv-4 (19), bam-2 (20), and syg-2
(21). egl-26 was previously reported to express in vulE and vulB2
cells (11). We found that a nuclear-localized egl-26::gfp tran-
scriptional fusion expressed in vulB1, vulB2, vulD, and vulE cells
(Materials and Methods). The expression was somewhat variable
and was observed starting from the mid-L4 stage and continuing
Fig. 1. The pattern of gene expression during late stages of vulval development. (A) An overview of vulval development. Lineal origins of 22 vulval nuclei are
indicated. ‘‘ABCDEFFEDCBA’’ refer to vulval cell types vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF. vulB is the only case in which a single VPC granddaughter
gives rise to two cell types (8). Vulval cell nuclei at each stage are positioned as indicated (left, anterior; right, posterior). (B) A summary of cell-type specificity
and timing of expression in the wild type (Materials andMethods) (9, 11, 13–21, 24–26). Boxes indicate stages at which gene expression is activated. The vertical
order of events within each time block is arbitrary. For egl-17, vulEvulF expression begins in P6.p (early L3) and persists in their descendants (vulE and vulF) until
turned off in the early L4 stage. This inactivation, which is regulated by lin-29 and lin-11, is indicated by the box marked ‘‘egl-17 OFF.’’ ceh-2 is expressed at a
higher level in vulB1 compared with vulB2. (C) Expression pattern of lin-11. The diagrammed pattern is based on the lin-11::gfp transgene syIs80 (26). (D)
Expressionpatternof cog-1.Thepattern is basedon the cog-1::gfp transgene syIs63 (13). (E) Thealteredpatternofgeneexpression in lin-29mutants (9, 23) (Tables
1 and 2). White boxes with the red outlines indicate loss of expression and loss of egl-17 down-regulation in the lin-29mutant. lin-29 appears to regulate events
that occur during the mid-L4 to the late L4 stage. (F) The altered pattern of gene expression in cog-1 mutants (Table 3 and Fig. 2). Arrows are drawn with the
assumption that both sy607 and sy275 phenotypes are caused by different reduction of function of the cog-1 gene. Filled boxes with red or blue outline indicate
ectopic expression. (G) Altered pattern of gene expression in lin-11mutants (26). (H) Altered pattern of gene expression in the egl-38mutant (16) (Tables 1 and
2). egl-17 expression in vulF is observed in the cog-1(sy275); egl-38 double mutant, suggesting a redundant repression mechanism.
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into the adult stage. The C55C3.5 gene encoding a novel protein
was previously found to express in vulval cells (I. Hope, personal
communication). We found that C55C3.5::gfp was expressed in
vulF cells, starting from the late-L4 and continuing into the adult
stage.
Several conclusions can be drawn from Fig. 1B. First, all seven
cell types exhibit distinct programs of gene expression, despite
the fact that these cells are related by cell lineage and function.
[vulB1 and vulB2 differ in the level of ceh-2 expression but
otherwise have similar expression profiles (9)]. Distinct expres-
sion profiles likely underlie distinct functions of vulval cell types.
For example, lin-3, which encodes an EGF-related signaling
protein, is expressed in vulF cells in the mid-L4 stage (16). This
signal is required for a vulva-to-uterus signaling that induces a
specific fate, uv1, in uterine cells adjacent to vulF.
The pattern of marker expression also reveals a strict temporal
regulation of gene expression (Fig. 1B). For example, cdh-3 is
expressed in early L4, F47B8.6 is expressed in late L4, and
T04B2.6 is expressed 1 day after the L4-to-adult molt (9). For
egl-17, ceh-2, zmp-1, and sqv-4, the timing of gene expression is
different for different vulval cells (9, 15, 19). For example, egl-17
is expressed in vulE and vulF cells in the L3 stage and in vulC
and vulD in the L4 stage.
Trans-Regulation of Vulva Gene Expression. The analysis of the
regulatory network controlling the pattern of gene expression in
the vulva has focused primarily on the effect of transcription
factor mutations on gene expression reporter transgenes. Inmost
cases, a direct transcriptional regulation of the target has not
been demonstrated. Key results are summarized in Fig. 1 E–H.
So far, important regulators are lin-29 (encoding Zn-finger
transcription factor; Fig. 1E) (9, 22, 23), cog-1 (Nkx6 homeodo-
main; Fig. 1 D and F) (13), lin-11 (LIM homeodomain; Fig. 1 C
and G) (24–26), and egl-38 (PAX 258; Fig. 1H) (16, 27).
A Temporal Regulator of Gene Expression. lin-29 is required for the
expression of egl-17 in vulC and vulD (23), ceh-2 in vulC (9), and
zmp-1 in vulD and vulE (Fig. 1E, Tables 1 and 2, and Fig. 5, which
is published as supporting information on the PNAS web site)
(9). By contrast, lin-29 in not required for the expression of cdh-3
in vulC, vulD, vulE, vulF (9), ceh-2 in vulB (9), egl-17 in vulE and
vulF (23), and zmp-1 in vulA (9). Moreover, the expression of
egl-17 in vulE and vulF is observed during the L4 stage (23),
suggesting that the mechanism that turns off egl-17 expression in
these cells is compromised (Fig. 5). These lin-29 phenotypes are
not easily explained by cell fate changes between vulval cell types
but suggest a temporal regulatory defect: lin-29 mutations cause
loss of events associated with themid-to-late L4 time points. This
interpretation of these data is particularly attractive, because
lin-29 mutations are known to cause heterochronic defects in
other tissues, specifically in the L4-to-adult transition in the
lateral hypodermis (22, 28, 29). lin-29 is expressed in all vulval
cells, starting in the mid-L3 stage and continuing through the L4
stage (30).
Cell-Type-Specific Regulators of Gene Expression. We analyzed the
effect of two cog-1 (Nkx6.16.2 homeodomain) mutations on the
expression of vulval-cell-specific gene expression reporters (Fig.
1F, Table 3, and Materials and Methods). cog-1(sy275) is a
missense mutation in the homeodomain, and cog-1(sy607) is a
small deletion that eliminates one of two cog-1 transcripts (13).
We found that in the mid-L4 stage, cog-1(sy275) caused ectopic
expression of egl-17 in vulE cells (Fig. 2) and ectopic expression
of ceh-2 in vulC, vulD, and vulE cells and loss of zmp-1 expression
in vulE cells. In contrast, cog-1(sy607) caused loss of cdh-3
expression in vulC, vulD, and vulE cells and loss of ceh-2
expression in vulB. These results indicate that egl-17, cdh-3,
ceh-2, and zmp-1 are regulated by the cog-1 gene. Although some
cog-1 expression is observed in all vulval cells, gfp reporters
suggest that cog-1 is most strongly expressed in vulC and vulD
and weakly in vulE and vulF, implying a cell-type-specific
function (13) (Fig. 1D).
A somewhat similar situation is presented with lin-11 (LIM-
homeodomain) (Fig. 1 C and G). During the L4 stage, lin-11 is
expressed strongly in vulB, vulC, and vulD and weakly in other
vulval cells, suggesting that lin-11 is involved in the specification
of these cell types (24, 26). However, unexpectedly, lin-11 is
cell-autonomously required for expression of most vulval genes
tested, including in cells where the lin-11 level is low (26).
egl-38 is a PAX258 transcription factor required for expres-
Table 3. Expression of egl-17, ceh-2, and cdh-3 in cog-1 mutants
Reporter Mutations vulA
vulB1 and
vulB2 vulC vulD vulE vulF
egl-17  0 0 100 100 0 0
egl-17 cog-1 (sy275) 0 0 100 92 92 0
egl-17 cog-1 (sy607) 0 0 93 100 0 0
ceh-2  0 100 0 0 0 0
ceh-2 cog-1 (sy275) 20 90 80 80 88 0
ceh-2 cog-1 (sy607) 0 0 0 0 0 0
cdh-3  0 0 100 100 100 100
cdh-3 cog-1 (sy275) 0 0 100 100 100 100
cdh-3 cog-1 (sy607) 0 0 14 14 71 94
Percentagesof cells inmid-L4animals that expressedegl-17::gfp, ceh-2::gfp
and cdh-3::gfp. See Table 4, which is published as supporting information on
the PNAS web site, for number of cells scored.
Table 1. Expression of zmp-1 in vulE and vulF cells
Genotype vulE vulF No. of animals
Wild type   80
lin-11   55*
lin-29   50†
cog-1 (sy275)   52
egl-38   48
lin-11; egl-38   52
lin-29; egl-38   56
cog-1; egl-38   56
*Ref. 26.
†Ref. 9.




Wild type   59
cog-1 (sy275)   46
egl-38   38
cog-1; egl-38   37
lin-11 —* —* 45†
lin-29 —* —* 43‡
lin-11; lin-29 —* —* 38
lin-11; cog-1 —* —* 43
lin-29; cog-1 —* —* 40
lin-11; cog-1; egl-38 —* —* 35
lin-29; cog-1; egl-38 —* —* 36
*These cells express egl-17::gfp at a low level. We interpret these as the
persistence of L3 expression.
†Ref. 26.
‡Ref. 23.
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sion of the lin-3 gene in vulF cells (16, 27). We found that egl-38
represses expression of zmp-1 in vulF cells, indicated by ectopic
zmp-1 expression in egl-38 mutants (Fig. 1G and Table 2). In
addition, in an egl-38; cog-1 double mutant, egl-17 is expressed in
both vulE and vulF cells. Thus, egl-38 is also capable of repressing
egl-17 expression in vulF cells, although in the wild type, this
function is redundant with the cog-1-dependent mechanism that
restricts egl-17 expression to vulC and vulD. egl-38 is currently the
best example of cell-type-specific factors, promoting expression
of some genes (lin-3) and repressing expression of others (zmp-1,
egl-17) in a single cell type, vulF.
Regulators of the Transcription Factor Network. The transcription
factor network that regulates gene expression in individual cell
types must be regulated by the cell-fate-patterning mechanism
that specifies each cell to a specific fate and does so in a spatially
precise pattern. In the vulva, the cell types occur in a specific
ABCD-EFFE-DCBA pattern (Fig. 1A). Although the full mech-
anism that establishes this pattern is not known, Wnt signals,
mediated by lin-17 (Frizzled-type Wnt receptor) and lin-18
(Ryk-typeWnt receptor), control the anteriorposterior order of
cell types among P7.p descendants (31, 32) (Fig. 3). Analysis of
cog-1 (31) and lin-11 (25) expression in lin-17 and lin-18mutants
indicates that Wnt signaling establishes the correct spatial pat-
tern of transcription factor expression. As described above
(Tables 1 and 3 and Fig. 1 F andG) (26), cog-1 and lin-11, in turn,
control the expression pattern of egl-17 and cdh-3. Patterns of
egl-17 and cdh-3 expression observed in lin-17 and lin-18mutants
are consistent with high levels of cog-1 and lin-11 turning on the
expression of these genes (31, 32). Another set of cell-fate-
patterning mechanisms controlling gene expression was revealed
by the analysis of vulE vs. vulF fate specification using the zmp-1
reporter. A dominant-negative Ras or the ablation of the anchor
cell disrupts the pattern of zmp-1 expression in presumptive vulE
and vulF cells, indicating that a Ras-mediated signal, probably
from the anchor cell, establishes the spatial pattern of cell
fates (17).
These results confirm that cell–cell communication is impor-
tant in patterning cell fates, and that signaling pathways operate
through the transcription factor network to control the pattern
of gene expression. Expression patterns of various genes (Fig. 1
B–D) suggest that transcription factors are expressed in all vulval
cells at different levels, whereas genes regulated by them have
relatively simple onoff patterns of expression. This difference
suggests that the spatial pattern becomes progressively more
refined as the information is passed through the regulatory
network. This progressive refinement of pattern is likely a
consequence of integration of information from multiple regu-
latory mechanisms, such as intercellular communication and
feedback regulation. Many of these disparate data inputs are
likely processed at the level of cis-regulatory modules. Thus, the
Fig. 2. Regulation of egl-17 by cog-1. (A and B) Nomarski and epifluores-
cence images of wild-type mid-L4 animal carrying the egl-17::gfp transgene.
Arrows point to vulE nuclei. vulE cells are not fluorescent. (C and D) cog-
1(sy275) animals at the same stage carrying the egl-17::gfp transgene. vulE
cells are fluorescent.
Fig. 3. Link between cell fate patterningmechanisms andgene expression. In general, inductive signals regulate transcription factor networks to regulate gene
expression. In the P7.p (but not P5.p) lineage, Wnt signals transduced by lin-17 and lin-18 control the pattern of cog-1 and lin-11 expression (25, 31). cog-1 and
lin-11 in turn regulate egl-17 and cdh-3 expression (Table 3) (26). It has not been determined whether cog-1 and lin-11 regulate each other. In the P6.p lineage,
an anchor cell signal anda let-60Ras signal transductionpathway are required to establish the correct patternof zmp-1 expressionpattern (17). zmp-1 expression
is also repressed in vulF by egl-38 PAX258 (Table 1). It is not known whether the patterning mechanism acts through egl-38. The expression pattern of egl-38
is also not known.
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spatial pattern of transcription factor effects becomes more
restricted than the spatial pattern of transcription factor expres-
sion. This hypothesis is consistent with the observation that cells
affected by lin-11 and cog-1mutations do not correspond directly
to cells that express high levels of lin-11 and cog-1.
cis-Regulation of Vulva Gene Expression. cis-regulatory elements
(e.g., enhancers) have been analyzed in detail for several genes
expressed in the vulva, most notably egl-17, cdh-3, and zmp-1,
using transgenic assays (33, 34). A comparative genomics anal-
ysis of the regulatory region of orthologs from C. elegans and
Caenorhabditis briggsae has also proved useful.
Here, we focus on the analysis of the egl-17 gene. As shown in
Fig. 1B, this gene is expressed in vulE and vulF cells during the
L3 stage and in vulC and vulD cells during the L4 stage.
Dissection of the 5 regulatory region revealed that there are
three separable enhancer elements, two driving expression in
vulE and vulF and one driving expression in vulC and vulD (33,
34) (Fig. 4A). Notably, each of these elements drives expression
at different times. The distal vulEvulF element drives expres-
sion in the mid-L3 to early-L4 and the proximal vulEvulF
element drives expression in the early to mid-L3 stage (34). The
vulDC element drives expression in the mid-L4 stage. Thus, the
expression of egl-17 is produced by the composite activity of
three discrete enhancers, each of which drives both spatially and
temporally restricted pattern of expression. We propose two
models for how the information that operates on these enhancers
is integrated. In one model (Fig. 4B), temporal (blue) and spatial
(red) regulators both bind directly to the egl-17 promoter, and
information integration is achieved directly on the cis-regulatory
element. Alternatively, transcription factors that bind to each of
these promoters may already combine temporal and spatial
information (Fig. 4C). Our results indicate that the vulDC
element regulating mid-L4 expression is likely regulated by
lin-29, lin-11, cog-1, and egl-38. Additional experiments are
necessary to determine the molecular mechanism of information
integration.
Conclusion
The late vulval development of C. elegans offers an excellent
system in which to investigate cell fate determination and
regulation of cell-type-specific gene expression. In particular,
this system combines single-cell resolution with a high degree
of temporal resolution in an easily manipulated model organ-
ism. In many respects, vulval development is reminiscent of
other systems in that transcription factors are expressed in
overlapping domains, and the identity of each domain is
established combinatorially by the presence or absence of
specific subsets of these transcription factors. One interesting
example with possible parallels to the vulva is the fate-
specification mechanism in the vertebrate ventral neural tube
(35). In this system, Nkx6.1 and Nkx6.2 homeodomain proteins
(homologs of cog-1) interact with transcription factors Dbx1
and Dbx2 in a mutually repressive network, and different
activities of repressor proteins help establish the spatial pat-
tern of cell fates (36, 37). It is possible that C. elegans cog-1
functions in a similar manner in the vulva.
Analysis of vulval development also highlights several features
that are not necessarily evident in other systems. First, analysis
of vulval development has revealed a highly complex pattern of
temporal regulation, which is undoubtedly a feature of most
organogenetic processes (for example, see refs. 38 and 39). The
involvement of lin-29, a known regulator of stage-specific de-
velopment in C. elegans, suggests that the global mechanism of
temporal regulation feeds into the development of this particular
organ. Additional mechanisms probably exist that control ex-
pression at other time points. Whether these other time points
are regulated by a global mechanism or in an organ-autonomous
manner is not yet clear.
One concept that has been invoked in analyses of cell or organ
fate specification is that of ground state and selector genes. For
example, in Drosophila appendage development, it has been
proposed that a default ‘‘ground state’’ exists and is modified by
‘‘selector’’ genes to produce an antenna or a leg (40). The
concept can be applied to the level of individual cell types as well
(for example, ref. 41). From this point of view, the cell-type-
specific transcription factors cog-1, lin-11, and egl-38 can be
thought of as selector genes for subsets of vulval cell types. What
is the ground state of vulval cells in the absence of selector genes?
A cell in such a state presumably will not express the cell-type-
specific genes described in Fig. 1 but will retain the epithelial
identity common to all vulval cells. It is unclear whether such a
state has been observed in any of the mutants. Vulval cells in
lin-11 mutants lack most cell-type-specific expression but retain
the ability to undergo some morphogenetic movements charac-
teristic of vulval cells and thus may most closely resemble the
ground state.
In other systems, analyses of coregulated genes have suc-
cessfully identified ‘‘gene batteries’’ (42), sets of genes with
common cis-regulatory elements that are coexpressed (for
example, ref. 43). However, our understanding of vulval
development is still limited, relative to the number of cell types
Fig. 4. cis-regulatory elements of egl-17. (A) A map of the egl-17 5 regula-
tory region. Boxes indicate enhancer elements defined by Cui and Han (34)
and Kirouac and Sternberg (33). ‘‘AND’’ and ‘‘OR’’ logic gate symbols indicate
sites and logic of information integration. Temporal (blue) and spatial (red)
information is integrated as indicated by the logic circuit diagram to produce
the complete egl-17 expression pattern. In one model (B), spatially and
temporally regulated transcription factors each bind directly to the egl-17
cis-regulatory region. The integration of information takes place on enhancer
elements. In the alternative model (C), spatial and temporal cues are inte-
grated at the transcription factor level. These transcription factors (purple)
with both spatially and temporally restricted activity regulate each enhancer
element.
4976  www.pnas.orgcgidoi10.1073pnas.0408122102 Inoue et al.
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and the number of distinct stages that require different gene
expression patterns. Consequently, within the relatively small
number of functionally unrelated genes analyzed so far, genes
are more likely to be regulated by distinct mechanisms. Thus,
although gene batteries with multiple genes probably exist in
this system, their analysis requires knowledge of more genes
and a detailed understanding of which transcription factors
regulate their expression.
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Abstract 
 Transcriptional regulation is a major mechanism directing development.  
However, demonstration of direct transcriptional regulation through identification of cis-
regulatory elements and corresponding trans-acting factors is a significant bottleneck in 
the analysis of developmental processes. During the vulval development of 
Caenorhabditis elegans, seven terminally differentiated cell types are produced that 
express distinct sets of genes. A network of mutually interacting transcription factors 
controls the expression of these genes. While the identity of some transcription factors 
are known (COG-1, EGL-38, LIN-11, LIN-29, and NHR-67), genes and cis-regulatory 
elements directly regulated by them have not been identified.  To identify such 
interactions, we carried out a screen for cis-regulatory elements that direct gene 
expression in vulval cell types. First, we identified candidate ~ 200 base pair (bp) 
enhancer regions from genomic sequences upstream of 17 vulva-expressing genes using 
sequence conservation between C. elegans and C. briggsae. Second, we tested the ~ 200-
bp regions in vivo for enhancer activity. Of the 32 regions tested, 22 exhibited expression 
in some cell or tissue, nine of which showed vulval activity.  Third, by using six of these 
regions as DNA “baits” in a yeast one-hybrid (Y1H) system, we identified transcription 
factors that bind three of these regions.  Characterization of these factors indicated that 
the zinc finger transcription factor ZTF-16 plays a role in both vulval induction and 
vulval terminal cell-fate specification.  These results demonstrate a set of procedures that 
can be used to efficiently identify small enhancers and regulators that interact with them. 
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Introduction 
 Tissue- and stage-specific gene activity is controlled through a variety of 
mechanisms, however, during development transcriptional regulation is the most 
common mechanism (1). Transcriptional regulation is achieved through cis-regulatory 
elements encoded in the genome in close proximity to the protein-coding region. These 
sites are bound by factors that determine the transcriptional state of the gene in a cell-type 
and developmental stage-specific manner. In general, cis-regulatory elements controlling 
transcription are organized into promoters and enhancers. Promoters reside immediately 
upstream of the transcription start site and the loading site for RNA polymerases. 
Enhancers reside at various distances from the promoter and activate transcription from 
the promoter. Although enhancers are most commonly located to the 5' of the promoter 
region, they are also found to the 3' of the gene, and in introns (1, 2).  
 Identification of cis-regulatory elements remains a major challenge. Classically, 
such elements were identified through the dissection of regulatory genomic sequences in 
successive steps using an in vivo (transgenic) assay system at every step to follow the 
regulatory activity (3, 4). Although powerful, such analyses are arduous and not easily 
amenable to a large-scale effort. The availability of genomic sequences from a number of 
closely related species provides a potential shortcut. Since genomic sequences in different 
species diverge over time due to mutation and genetic drift, any conservation suggests a 
purifying selection, which in turn indicates that that sequence has a function.  Conserved 
sequences outside of the protein-coding region often correspond to cis-regulatory 
elements (1, 5, 6). 
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 C. elegans is an excellent model system for analysis of development (7).  Because 
nematode development is mostly invariant at the cellular level, this system offers single-
cell resolution for investigating developmental processes (8). In particular, we have been 
analyzing late-stage development of the vulva as a model in which to study 
differentiation and gene expression control during organogenesis (9–11). The C. elegans 
vulva is derived from three precursor cells, P5.p, P6.p, and P7.p, which are induced to 
adopt vulval fates by a combination of EGF, Wnt, and Notch signaling. These three cells 
undergo three rounds of division near the end of the third larval (L3) stage to produce 
cells of seven distinct terminally differentiated cell types, each of which expresses a 
unique combination of genes. Several transcription factors are known that are required 
for the correct pattern of gene expression in these cells. These include COG-1 (Nkx6 
homeodomain) (12), EGL-38 (PAX 2/5/8) (13, 14), LIN-11 (LIM homeodomain) (15, 
16), LIN-29 (zinc finger) (18), and NHR-67 (nuclear hormone receptor) (19). These 
genes are linked by a complex network of mutual- and auto-regulatory interactions and 
constitute a gene regulatory network (GRN), which is required to establish cellular 
identity and direct cell-type-specific gene expression. Thus, the full understanding of the 
system requires the identification of multiple regulatory interactions.  
 Here we describe a series of screens to identify cis-regulatory interactions in the 
vulval GRN.  Because previous analyses indicated that most enhancer elements are 
conserved between C. elegans and C. briggsae (5, 20, 21), we used conservation to 
identify 200-bp candidate enhancer regions, which we tested for activity in vivo using a 
fusion-PCR/biolistic transformation pipeline. Starting from seventeen genes, we tested 32 
regions and found 22 enhancer regions, nine of which displayed vulval enhancer activity.  
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Next we subjected six vulval enhancers to yeast one-hybrid (Y1H) analysis.  Using a 
library of known and putative C. elegans transcription factors we identified five 
transcription factors that bind three of these regions in yeast.  We then determined if these 
factors play roles in the vulval GRN by screening the available mutants for possible 
vulval phenotypes and for effects on enhancer and reporter gene expression.  One of the 
factors identified by the screen, ZTF-16, is expressed in all vulval cells, and a ztf-16 
deletion mutant exhibits defects in vulval morphology and gene expression.  Together, 
our analysis suggests a set of parameters for single-step identification of C. elegans gene 
enhancer elements that can be successfully used in Y1H analysis. 
Results 
Selection of Candidate Enhancer Elements.  We began our analysis with a set of 31 
genes that are expressed in the vulval cells (Table 1).  One additional gene, grl-1, was 
included because preliminary reports had suggested vulva expression.  From these 32 
genes, we selected 17 (boldface in Table 1) that have a probable ortholog in C. briggsae, 
and whose upstream regions have not been previously investigated.  For each gene from 
C. elegans and C. briggsae, we took the sequence of the region 2-kb (kilobase = 1000 
bases) upstream of the ATG start codon, or in cases where the upstream gene was closer 
than 2-kb from the ATG, up to the next gene. Upstream regulatory regions from C. 
elegans and C. briggsae were aligned using the clustalw program under default 
parameters.  
 To make later stages of the screen more uniform, we focused our initial efforts 
exclusively on ~ 200-bp candidate regions. Previous analyses of vulval enhancers found 
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that minimal functional enhancers are typically in the range of 50 to 150-bp (20, 21). To 
select 200-bp candidate regions from these alignments, we selected 150-bp windows that 
showed high degrees of conservation. High-scoring regions were “padded” on each end 
with 25 additional bases to generate 200-bp regions. We also allowed a maximum of 100-
bp overlap between adjacent regions to ensure that highly conserved sections of the 
genome are always contained in one or more candidate regions (see Materials and 
Methods for full description of the algorithm). Some genes, including pax-2, returned no 
candidate regions of high score by this analysis, even though a visual scan of the 
alignment suggested that these promoters contained regions smaller than 150-bp that 
show a high degree of sequence similarity. To include pax-2 in our analysis, we used a 
modified set of parameters in which 50-bp regions with a high degree of conservation 
were identified and padded with 75 bases on either end to generate 200-bp regions. 
Candidate regions identified from the 16 genes and pax-2 were merged into a single list 
and sorted by the score (score = identical bases out of 150). We normalized the scores for 
pax-2 (identical bases out of 50) by multiplying the score by three. From the merged list, 
we selected the 48 highest-scoring regions (named RGN7 through RGN54) for in vivo 
analysis of enhancer activities (Table 2). 
 
In Vivo Analysis of Enhancer Activity.  To assay enhancer activity of candidate 
regions, we utilized the delta-pes-10::GFP construct that contains a naive promoter 
upstream of the gfp (green fluorescent protein) coding region (22–24). The !-pes-10 
promoter displays little to no transcriptional activity on its own, but can be enhanced in a 
tissue- and stage- specific manner when an enhancer is linked in cis to the promoter.  One 
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caveat of this assay system is that some enhancers that activate their native promoters 
may not act on the !-pes-10 promoter (25).  However, previous analyses suggested that 
the !-pes-10 system could detect most of the enhancer activity present upstream of egl-
17, cdh-3, and zmp-1 (20, 21). Thus, this system is likely to detect a significant fraction 
of enhancer activity present in these fragments.  
 To link our candidate enhancers to !-pes-10::GFP, we used fusion-PCR 
(Materials and Methods). Fusion-PCR products were then introduced into C. elegans by 
microparticle bombardment using unc-119(ed4) mutants and unc-119(+) plasmid DNA 
as a co-transformation marker. unc-119 mutants display severe morphological and 
behavioral defects, and transformed (rescued) animals are easy to find and select for (26). 
Although recommended in some published protocols, we did not find it necessary to 
covalently link the transformation marker to the fusion-PCR product, possibly because 
we used a larger quantity of DNA per bombardment. In a pilot experiment, we found that 
nine out of ten independent transgenic lines made from co-bombardment of unc-119 and 
an enhancer::!-pes-10::GFP fusion PCR product expressed GFP in a near-identical 
pattern (see Materials and Methods). Nevertheless, during our analysis of candidate 
regions, we found multiple cases where non-expressing and expressing lines were 
obtained using the same pool of fusion-PCR products.  To reduce error from such non-
expressing lines, multiple lines were analyzed for each region tested (typically two lines). 
Finally, we tested for and found no difference in expression pattern between transgenic 
lines made by bombardment and lines made by microinjection (see Materials and 
Methods). 
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Expression Patterns.  Expression of GFP in transformed animals was examined first on 
a dissecting microscope equipped for epifluorescence (up to 66x magnification). In cases 
where vulval expression was observed or was suspected, animals were examined on a 
compound microscope (typically 1000x magnification).  
 We generated lines for 32 of 48 candidate regions selected, and found that nine of 
32 candidate regions (RGN7, 12, 14, 16, 17, 21, 28, 30, and 44) drove expression in 
vulval cells (Table 2). Expression in other tissues was observed in 13 additional lines. 
This was expected, since the full-length upstream regulatory regions for some of the 
genes drive expression in tissues other than the vulva, and we had no way of determining 
a priori which conserved regions are likely to be vulva-specific. Altogether, about two 
thirds of the regions tested showed enhancer activity in some tissue.  Regions with scores 
above 95 (= 95 identical bases out of 150) typically expressed GFP at a high level in a 
distinct spatial pattern (RGN7, 14, 16, 17, also non-vulval enhancers including RGN9, 
11). In contrast, regions with lower scores (RGN21, 28, 30, 44) often expressed GFP at a 
low level (Figure 1). Although the spatial pattern was often difficult to discern because of 
the low level of expression, many of these lower-scoring lines appear to express GFP in 
all or a large number of vulval cell types. Because regions with scores above 95 often 
give stronger enhancer activity, we concentrated our efforts on regions with scores above 
85 (RGN7-RGN28), and transgenes were not generated for some of the low-scoring 
regions. RGN12, which was identified using the 50-bp window, displayed a bright and 
distinct expression pattern (score of 34/50-bp identity = 102 normalized). This is 
significant in that the scan of the same alignment using a 150-bp window did not return a 
high-scoring candidate region; the highest scoring candidate region using the 150-bp 
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window was 78/150. Thus, in some cases, using a smaller window can identify regions 
missed using a larger window size. Finally, some regions with high scores (e.g., RGN8) 
did not exhibit obvious enhancer activity in multiple transgenic lines we examined.  
 Spatial and temporal patterns of vulval enhancer activity were examined in detail. 
Expression patterns observed varied in their similarity to the patterns generated by more-
complete regulatory regions (compare Table 1 and Table 2). Some regions (e.g., RGN7 
from grl-4) faithfully reproduced the expression of the more complete upstream 
regulatory region. Some regions had a more restricted expression pattern than the more 
complete regulatory region (e.g., RGN17 from sqv-4). This was expected, since multiple 
enhancer elements typically contribute to the total transcriptional activity of an upstream 
regulatory region. Similar restricted expression patterns have been observed for 
enhancers from egl-17, cdh-3, and zmp-1, in comparison to the complete upstream 
regulatory region (21). Finally, in some cases expression in unexpected vulval cell types 
was observed (e.g., RGN12 from pax-2). The observation of GFP expression in 
unexpected cell types suggests the presence of repressor elements in the regulatory 
region, although it is also possible that !-pes-10 is failing to interact correctly with the 
enhancer. 
 
Screen for 80-bp Regions with Enhancer Activity.  Some of the vulval enhancers 
previously described are as small as 60-bp. To attempt to determine the minimal element 
required for enhancer activity, we subdivided each of five regions with vulval enhancer 
activity (RGN7, 12, 14, 16, 28) into three equal sub-regions of 80-bp. The three sub-
          III-9
regions together cover the original ~ 200-bp region with about 20-bp of overlap between. 
These sub-regions were fused to !-pes-10::GFP and were tested in vivo as with larger 
fragments. We found that four sub-regions from three regions (RGN7, RGN14, RGN28) 
exhibited enhancer activity in vulval cells (Table 3). Sub-regions of RGN12 and RGN16 
failed to drive expression, perhaps indicating that these ~ 200-bp regions were close to 
the minimal functional enhancer. 
 
Yeast One-Hybrid Analysis.  Using six of the RGNs with vulval enhancer activity as 
DNA “baits,” we conducted yeast one-hybrid analysis (27).  Briefly, each DNA “bait” 
was cloned upstream of two reporter genes, HIS3 and lacZ, to create DNAbait::reporter 
constructs, and these were subsequently mated to an array of ~ 750 C. elegans 
transcription factors (80% of all predicted) (28).  Two reporter constructs are used for 
each “bait” to reduce the rate of isolating false positives.  Generally, only clones that 
score positively in both reporter assays (double positives) are considered high-confidence 
interactions.  However, as some clones rarely interact with DNA, positive results for such 
clones (rare hits) were also pursued further.  The Y1H screen identified six protein-DNA 
interactions involving five transcription factors and three RGNs (Table 4).  That the Y1H 
analysis did not identify interactors for all six of the RGNs tested is not unexpected since 
this system exhibits a false negative rate of up to 67%, consequently, RGNs that did not 
return positive interactions may still interact with known transcription factors in vivo 
(27). 
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 Among five transcription factors that were either double-positives or rare hits, we 
were able to obtain deletion alleles of cey-1 (cold-shock/Y-box), the orphan nuclear 
hormone receptors nhr-43 and nhr-102, and ztf-16 (zinc finger).  These mutations 
allowed us to test if these transcription factors affect transgene expression in C. elegans.  
We conducted two tests with each mutation, one with the relevant ~ 200-bp RGN 
reporter transgene and one with a more-complete reporter transgene.  For example, to test 
the interactions between cey-1 and RGN16 we constructed and scored the vulval 
expression of two strains, cey-1(ok1805); RGN16::!-pes-10::GFP [syEx824] and cey-
1(ok1805); F48B9.5::GFP [leEx1519].  The results of the RGN strains are summarized 
in Table 5, the ztf-16 strains are described below and in Figure 2 and Table 5, and all 
other strains are summarized in Supplemental Table 1.  Mutations in three of the five 
Y1H-identified protein-DNA interactions we tested caused either up- or down-regulation 
of enhancer element reporter construct expression in vulval cell subsets.  Both the ztf-16 
and nhr-102 mutations affected expression of the pax-2::GFP [guEx64] reporter, and ztf-
16 affected expression of the sqv-4::GFP [nEx851] translational reporter.  These results 
indicate that many protein-DNA interactions identified in yeast exhibit biological 
relevance in the worm.  
 
ZTF-16 and the Vulval GRN.  Of the transcription factors identified by the Y1H 
analysis, ztf-16 possesses the most characteristics commensurate with a role as a 
component of the vulval GRN.  ztf-16 encodes a DNA-binding protein with eight C2H2 
zinc fingers with reported similarities to the Ikaros family of transcription factors (29).  
ztf-16(ok1916) is a 1005-bp deletion that disrupts predicted zinc-fingers three and four.  
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The vulvae of 25% of ztf-16(ok1916) mutant animals are under-induced (n=59) (Figure 
3).  An expression reporter for the ztf-16 gene, ztf-16::GFP [sIs12144], was previously 
reported to be expressed in the pharynx, intestine, seam cells, and unidentified cells in the 
tail (30, 31).  We found that this reporter was also expressed in vulval cells.  In the wild 
type, all cells present in the adult vulva are generated by the onset of the L4 stage. Vulval 
morphogenesis and differentiation occur during the L4 stage which spans approximately 
12 hours at 20˚C.  In order to better describe dynamic expression patterns during vulval 
morphogenesis, we divided this timeframe into 10 sub-stages that we have termed L4.0–
L4.9 (Supplemental Figure 1).  Further analysis of ztf-16::GFP revealed expression in the 
VPCs and 2˚ vulval cells (vulA, vulB1, vulB2, vulC, and vulD), and faint expression in 
the 1˚ cells (vulE and vulF) (Figure 3).   Expression in the 2˚ cells was present from the 
onset of L4 and its intensity decreases beginning at L4.4; expression in the 1˚ cells is 
weak and difficult to quantify, but it appears most strongly during later L4 (L4.6–L4.8).      
 
ZTF-16 Regulates Expression of Vulval Genes.  ZTF-16 is a rare interactor in the Y1H 
system, but it was isolated as both a HIS-only positive with RGN12 and a “double 
positive” with RGN17.  RGN12 is a 199-bp putative pax-2 expression enhancer element 
just 40-bp upstream of the pax-2 ATG start site (Figure 4).  The Pax2/5/8 transcription 
factor pax-2 is the result of a recent duplication of egl-38; however, the two genes 
possess nonredundant characteristics (32, 33).  Due to its proximity to the ATG start site, 
the RGN12 enhancer may also exhibit promoter activity.   
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 In the vulva, the ~ 3.5-kb pax-2::GFP [guEx64] reporter consisting of the entire 
5’ upstream region, the first intron, and the majority of the second intron (Figure 4) is 
expressed in the vulE cells during very early L4 stage (L4.0–L4.1).  While vulE 
expression disappears during L4.1, expression is initiated in the vulD cells, and this 
expression steadily increases throughout L4 (Figure 2).  Vulval expression of the RGN12 
reporter does not appear to be as tightly regulated as the 3.5-kb pax-2::GFP.  Its 
expression is observed at a high frequency in vulC and vulD, and less frequently in 
vulB2, vulE, and vulF throughout the L4 stage (Table 5).  The difference in these 
expression patterns points toward a modular system of gene regulation including both 
enhancers and repressors.     
 The intensity of the vulD expression of 3.5-kb pax-2::GFP, however, is enhanced 
more than threefold during L4.2 and L4.3 in a ztf-16(ok1916) mutant background (Figure 
2).  The spatiotemporal patterning of ztf-16::GFP expression appears to coincide with the 
effect of the ztf-16 mutation on pax-2::GFP expression, indicating that ZTF-16 is a likely 
repressor of pax-2 transcription (compare Figures 2 and 3).   
 RGN17 is a 174-bp fragment containing an enhancer of sqv-4 expression, a gene 
that encodes a UDP-glucose 6-dehydrogenase (Drosophila Sugarless, Human UGDH).  
Both antibody staining and the translational sqv-4::GFP [nEx851] construct show 
expression in vulC, vulD, vulE, and vulF (34).  The RGN17 enhancer element drives 
expression primarily in vulC and vulD.  Another sqv-4 enhancer element RGN28 drives 
expression in vulE and vulF.  Consequently, these two enhancers likely represent two 
modules that work in concert to direct complete sqv-4 expression.  RGN17 expression 
was not affected by the ztf-16(ok1916) mutation (Table 5), but the frequency of sqv-
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4::GFP expression in the vulE cells was up-regulated (Figure 2).  These phenotypes 
suggest that in addition to a vulC- and vulD-specific enhancer, the RGN17 fragment also 
contains a vulE-specific repressor element responsive to ZTF-16.  These results suggest 




 Using a combination of computational searches for conserved sequences and fast 
in vivo enhancer assays using fusion-PCR/microparticle bombardment, we tested 32 
candidate enhancer regions from 17 different genes and found nine ~ 200-bp fragments 
that exhibited enhancer activity in our tissue of interest, the vulva. Furthermore, by 
subdividing five of these enhancers, we were able to identify four 80-bp fragments that 
exhibited enhancer activity in the vulva.  These newly discovered enhancer elements, 
which originate from regulatory regions of col-48, daf-6, F48B9.5, grl-4, pax-2, and sqv-
4, add to previously characterized vulval enhancers from egl-17, cdh-3, and zmp-1.  
 Currently, a basic blueprint of the gene regulatory network that directs vulval 
organogenesis is known.  A set of transcription factors involved in the network have been 
identified, and many of their linkages with target genes have been mapped.  There are at 
least two gaps, however, in our current understanding of this process.  First, there are 
likely additional transcription factors involved in the network that have not yet been 
identified.  Second, the directness of any of these interactions has not yet been 
demonstrated.  Utilizing a subset of the enhancers identified through our approach, in 
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combination with a robust Y1H system, we were able to identify four transcription 
factors that may be involved in the network.  In particular, we identified the zinc finger 
transcription factor ZTF-16 as a possible regulator of both vulval induction and terminal 
cell-fate specification.  Also, the ZTF-16-pax-2 protein-DNA interaction is the first direct 
linkage in the vulval gene regulatory network.   Other methods, including chromatin 
immunoprecipitation (ChIP) or ChIP coupled with microarray analysis (ChIP-chip) may 
reveal others.  
 The localization of the vulva-specific enhancer activity from a large (> 1-kb) 
fragment to an 80 or 200-bp fragment is highly significant. From the computational side, 
this represents a major reduction in the amount of noise while searching for candidate 
transcription factor binding sites. Experimentally, mutational analysis is facilitated by the 
small size, since small enhancers with wild-type or mutated sequences can be synthesized 
in vitro (our results not shown).   
 Various aspects of the candidate regions we tested suggest that, as in other 
systems, C. elegans vulva gene regulation is modular and complex. As observed 
previously, enhancers we discovered reproduce the expression patterns of the complete 
regulatory region to varying degrees. Interestingly, in addition to high-scoring enhancers 
that exhibited specific bright patterns of expression, we also found enhancers that were 
generally less conserved (i.e., low-scoring) and appear to exhibit low-level enhancer 
activity without strong cell-type specificity. Some of these weak enhancers are from the 
same gene as strong and specific enhancers. For example, RGN30, which exhibited weak 
enhancer activity, is derived from the same gene (sqv-4) as RGN17, which had a strong 
cell-type-specific expression pattern. An interesting possibility is that these enhancers 
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interact in the endogenous sqv-4 promoter, perhaps with RGN17 providing cell-type 
specificity and RGN30 interacting synergistically to increase expression level. Such 
examples are known from other systems (35).   
 Another interesting phenomenon is the case in which the enhancer activity is 
observed in an unexpected cell type. For example, RGN16 showed expression in vulA, 
vulB, and vulC cell types, even though the F48B9.5 upstream regulatory region from 
which this fragment is derived drives expression in vulC and vulD cell types only. Such 
cases suggest a possible repressor activity in the full-length region, and indeed, F48B9.5 
regulatory region harbors RGN8, which is highly conserved between C. elegans and C. 
briggsae, but showed no detectable enhancer activity in multiple independent transgenic 
lines. Further experiments investigating the patterns of interactions among enhancer and 
conserved elements are needed to investigate and detect these phenomena.  
 Our work demonstrates a method by which small enhancer elements can be 
identified rapidly from a set of genes of interest. About 70% of the candidate regions we 
tested displayed enhancer activity in some tissue. Thus, C. elegans/C. briggsae sequence 
conservation is an excellent computational filter by which potentially interesting regions 
can be identified. Furthermore, our analysis suggests that regions with a score over 
95/150 are likely to harbor strong cell-type-specific enhancers. Nevertheless, our 
approach is incomplete in that we found no vulval enhancers for the genes B0034.1, 
C55C3.5, egl-26, grd-5, grl-1, grl-10, grl-12, grl-15, and lin-11. There are a number of 
factors that might contribute to this problem: (1.) Enhancers for these genes may reside 
outside the 2-kb upstream region we analyzed. In particular we ignored potential intronic 
and 3' regions. Inclusion of these regions would not be difficult and we can use a set of 
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procedures essentially identical to the one we used to search these regions for candidate 
enhancer regions. (2.) These enhancers may not function in conjunction with !-pes-10 
naive promoter.  (3.) These genes may contain enhancers whose minimal extent is over 
200-bp, or our division of regions into candidate regions may have subdivided some of 
these into fragments too small to be active. (4.) The fusion-PCR bombardment protocol 
may be inefficient. (5.) The scoring scheme may need further optimization. For example, 
our result with the pax-2 enhancer suggests that such further optimization is useful. 
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Materials and Methods 
General Methods and Strains.  C. elegans strains were cultured on E. coli (OP50) at 
20˚C using standard protocols (36).  Alleles used in this study: LGII, cey-1(ok1805), a 
539-bp deletion that disrupts the coding region of the predicted cold-shock DNA binding 
domain; LGIV, nhr-43(tm1381), a 5-bp insertion and 542-bp deletion that disrupts the 
putative nuclear hormone receptor domain; LGV, nhr-102(tm1542), a 382-bp deletion 
that removes the putative ATG start site; and LGX, ztf-16(ok1916), a 1005-bp deletion 
that disrupts zinc-fingers three and four.  Transgenes used in this study: pax-2::GFP 
[guEx64], sqv-4::GFP [nEx851], F48B9.5::GFP [leEx1519], ztf-16::GFP [sIs12144], 
RGN7::!-pes-10::GFP [syEx764], RGN7a::!-pes-10::GFP [syEx967], RGN9::!-pes-
10::GFP [syEx765], RGN12::!-pes-10::GFP [syEx825], RGN14::!-pes-10::GFP 
[syEx834], RGN14b::!-pes-10::GFP [syEx968], RGN15::!-pes-10::GFP [syEx970], 
RGN16::!-pes-10::GFP [syEx824], RGN17::!-pes-10::GFP [syEx889], RGN21::!-pes-
10::GFP [syEx807], RGN25::!-pes-10::GFP [syEx766], RGN27::!-pes-10::GFP 
[syEx877], RGN28::!-pes-10::GFP [syEx808], RGN28a::!-pes-10::GFP [syEx969], 
RGN30::!-pes-10::GFP [syEx826], RGN32::!-pes-10::GFP [syEx878], and RGN44::!-
pes-10::GFP [syEx833]. 
 We reasoned that because vulval cells are specialized hypodermal cells, some of 
them may express collagen, a component of the C. elegans cuticle.  We therefore 
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searched the Nematode Expression Pattern Database (http://nematode.lab.nig.ac.jp/) for 
in situ hybridization results of collagen genes and found that col-7 and col-48 may be 
expressed in the vulva.  To test this, we constructed GFP transcriptional fusions of col-7 
and col-48, and found that they are expressed in subsets of the vulval cells. 
 
Identification of Candidate Regions.  C. elegans and C. briggsae genome sequences 
and orthology information were obtained from WormBase (data freeze WS140). 
Downloads of upstream regulatory sequence and alignment by clustalw 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) were done manually using a standard 
web browser and the MacVector software (http://www.macvector.com/). We wrote a 
short perl script to identify candidate regions and design primers. Sorting of candidate 
regions was done using Microsoft Excel (http://www.microsoft.com). 
 Candidate regions were selected as follows. First, the alignment was scanned with 
a 150-bp window and a score was assigned for each position of the window. The score 
was determined as the number of matched (identical) bases out of 150. Gaps (in C. 
elegans or C. briggsae sequences) were considered to be nonmatching. Next, the highest-
scoring window was selected and extended by 25 bases on either side. This defined the 
first region for the given alignment. Note that 200-bp regions were first defined with 
respect to the coordinate system of the alignment, and subsequently translated to the 
equivalent C. elegans genomic sequence. Thus, actual regions tested are shorter than 200-
bp in cases where the alignment contains a gap in the C. elegans sequence. After the first 
region was picked, window positions shifted from the first window by up to 100-bp on 
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either side were masked such that they could not be picked in subsequent scans. Then, the 
highest scoring unmasked region was picked as the second candidate region. This process 
was repeated until no regions with the score higher than 50 could be found. 
 The masking of 100-bp on either side of an already selected region ensures that no 
high-scoring region would be missed. If we mask out a wider region, two non-
overlapping regions in close proximity can block a region in the middle from ever being 
selected. By using a 100-bp blocking radius, we ensure that in order to block a region in 
between two regions already picked, the two regions would need to be touching. Thus, all 
high-scoring areas of the DNA would be contained in one or more candidate regions 
according to this scheme. 
 The primers were designed such that the 5' end corresponded to the outer edges of 
the candidate regions. Lengths (or 3' ends) of the primers were adjusted by the program 
to generate primers with an approximate Tm of 60°C. The primer sequences were checked 
manually and some were edited by hand prior to ordering. The complementary sequence 
to the end of !-pes-10::GFP fragment was added to downstream (3') primer to allow 
fusion PCR to occur. 
 
Fusion PCR.  Primers were obtained from IDT (http://www.idtdna.com). To minimize 
the number of primers that need to be synthesized, we used the following scheme 
(Supplemental Figure 2). The !-pes-10::GFP fragment was amplified from a vector 
containing the fusion (pP97.78) using primers PGdo and PGup3 (see Supplemental 
Materials for primer sequences). The candidate enhancer region was amplified from C. 
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elegans genomic DNA using region-specific primers RGNxf and RGNxr. The 5' end of 
RGNxr primers contained a segment complementary to the PGup3 primer, allowing for 
fusion PCR. The second round of amplification was done with primers RGNxf and 
PGdi3, using a mixture of the !-pes-10::GFP fragment and the candidate enhancer 
region fragment as the template. The primer PGdi3 is inset by 40 bases from the PGdo 
primer. This scheme minimizes the number of region-specific primers needed (two per 
candidate region) while reducing the possibility of misprimed product by the use of 
partially nested reaction (by the use of PGdo/PGdi3 pair). 
 For amplification and fusion of ~ 200-bp fragments, we used the Expand Long 
Template PCR kit (Roche) for all amplifications. For amplification and fusion of 80-bp 
fragments, we used ExTaq polymerase (TaKaRa) for the amplification of enhancer 
fragments, and Expand Long Template PCR kit (Roche) for other reactions. 30 to 40 
rounds of amplification were done for each step of the PCR fusion. Annealing 
temperatures of 50° to 60° were used for amplification of enhancer regions and adjusted 
when necessary.  
 
Microparticle Bombardment.  Microparticle bombardment was done as described with 
a few modifications (37). Some previously published protocols for transformation of C. 
elegans by microparticle bombardment call for covalent linkage of reporter fragment 
with a co-transformation marker. Because this involves ligation and cloning, this 
requirement imposed a potential bottleneck for the type of analysis we wished to carry 
out. To determine whether this was an absolute requirement, we carried out a pilot study 
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in which we co-transformed, using microparticle bombardment, fusion PCR products 
with the unc-119(+) co-transformation marker. For this analysis, we used fusions of 
enhancer regions RGN1 and RGN4 (see Supplemental Materials), derived from nas-37 
and pax-2 upstream regions, respectively. We coated gold particles with the mixture of 
fusion PCR product and unc-119(+) plasmid DNA and bombarded them into unc-
119(ed4) mutant animals. Animals rescued for the unc-119 mutation were picked to 
establish lines and examined for GFP expression. We found that four of five lines 
generated from co-transformation of RGN1 PCR product and unc-119(+) plasmid 
expressed GFP in a similar pattern. The one line that did not express was derived from 
bombardment using 0.25 micrograms (µg) of unc-119(+) and RGN1 DNA per 
bombardment. In contrast, when 1 µg or greater quantity of unc-119(+) and PCR product 
(each) was used per bombardment, GFP expression was consistently observed in unc-119 
rescued lines. To test whether there were differences between lines generated by 
microparticle bombardment and microinjection, we generated 2 lines by coinjection of 
unc-119(+) and RGN4 PCR products into unc-119(ed4) animals. We found that the 
expression pattern was identical in 3 of 4 lines made by microparticle bombardment and 
the two lines made by injection. One line made from microparticle bombardment 
exhibited a slight difference in expression, with expression in vulC cells. Based on the 
results of these pilot experiments, we carried out most of our experiments by bombarding 
mixtures of about 1 µg of PCR products and 1 µg of unc-119(+) plasmids. In order to 
reduce the problem of nonlinkage, we typically analyzed at least two lines for each region 
to be tested. Each population of worms was bombarded 2 to 4 times with separate 
populations of DNA coated beads. 
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 Yeast One-hybrid Analysis.  RGN7, RGN12, RGN14, RGN16, RGN17, and RGN30 
(for chromosomal coordinates see Table 2) were cloned upstream of two reporter genes, 
HIS3 and lacZ, to create DNAbait::reporter constructs, and these were subsequently 
mated to an array of ~ 750 C. elegans transcription factors (80% of all predicted) using a 
protocol described previously (27).    
 
Microscopy and Expression Analysis.  Worms were anesthetized using 3 mM 
levamisole and observed using Nomarski optics (http://www.nomarski.com/).  Images 
were taken with a monochrome Hamamatsu digital camera 
(http://www.hamamatsu.com/) and Improvision Openlab software 
(http://www.improvision.com/).  GFP reporter expression was quantified using Openlab.  
Mean pixel intensity was measured in the brightest region of the cell of interest, 
normalized for exposure time, and then this value was divided by the normalized mean 
pixel intensity of a non-expressing cell to derive the relative GFP intensity.  
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Figure Legends 
Figure 1.  Signal intensity correlates with degree of sequence conservation.  Lateral 
images of the developing vulva during the L4 stage.  Fluorescence (left), Nomarski 
(center), and overlaid (right) images are shown.  Expression patterns of three enhancer 
transgenes (RGN7, RGN21, and RGN 30) are shown along with their scores (= number 
of identical bases out of 150).  The fragment with the highest score, RGN7, exhibits the 
brightest expression.  The signal intensity and spatial resolution decreases in fragments 
with lower scores, RGN21 and RGN30, respectively. 
 
Figure 2.  Expression of pax-2 and sqv-4 are altered in a ztf-16 mutant background.  
(A)  pax-2::GFP expression in vulD cells during L4.2-L4.3 is enhanced in a ztf-16 
background.  (B)  Each image pair, Nomarski (top) and fluorescence (bottom), represents 
a single animal.  For comparison of pax-2::GFP expression in wild type and ztf-16 
mutant backgrounds, five randomly-selected animals at each L4 sub-stage were imaged, 
and all images were collected with a 25 millisecond exposure time.  (C)  The percent of 
animals exhibiting sqv-4::GFP expression in vulE is increased in a ztf-16 mutant 
background (P = 0.0033). 
 
Figure 3.  ztf-16(ok1916) exhibits a vulval phenotype and ztf-16::GFP is expressed in 
the vulva.  The ztf-16(ok1916) allele exhibits an under-induced vulval phenotype in ~ 
25% of animals.  Only two VPCs are induced in animals shown.  Expression of ztf-
16::GFP [sIs12144] in the 2˚ cells (vulA-vulD) is present from the onset of the L4 stage, 
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and at mid-L4 the expression intensity appears to decrease.  Weak expression is also 
present in the 1˚ cells; it is difficult to quantify, but it appears most strongly from mid- to 
late L4. 
 
Figure 4.  Gene models of F48B9.5, sqv-4, and pax-2.  F48B9.5, sqv-4, and pax-2 are 
shown with exons represented by turquoise rectangles.  The relative positions of the 
nearest 5’ upstream genes (gray gene models) are indicated for sqv-4 and pax-2.  
F48B9.5’s nearest 5’ upstream gene, nlp-7, is located ~ 14-kb away and is not shown.  
Below each gene model the WABA C. briggsae alignments are shown 
(http://wormbase.org/).  The light blue to dark blue regions code for low-to-high 
similarity regions, respectively.  The green rectangles indicate the regions of sequence 
used to generate the reporter constructs referenced in this work.  The numbered red 
rectangles show the positions of the predicted RGN enhancer elements.  The expression 
patterns of each reporter are indicated.  For reporters with vulval expression, cartoons of 
the L4 stage vulva with vulval cell nuclei represented by circles are used.  Filled circles 
indicate the presense of expression and empty circles indicate absence of expression.  (*) 
The pax-2::GFP expression in the vulE cells is present only during very early L4.  
 
Supplemental Figure 1.  Set of characteristics for scoring L4 sub-stages.  Times 
indicated are approximate hours (hr) after L3/L4 molt.  (L4.0)  0 hr; vulA, vulB, and vulE 
have divided, but vulC and vulF have not. (L4.1)  1.5 hr; vulC and vulF have now 
divided, and a narrow lumen has formed.  (L4.2)  Lumen has widened, and a prominent 
          III-31
kink (arrow) has formed between vulC and vulD.  (L4.3)  4 hr; vulFs have separated and 
the apex of the lumen is flat and capped by the anchor cell (arrow).  (L4.4)  5.5 hr.; utse is 
visible as a thin layer separating the vulval and uterine lumens (arrow).  (L4.5)  The side 
of the vulval lumen between vulC and vulD (arrow) is more curved.  At sub-stage L4.4, 
the ventral side of vulD is convex, and the concave part against vulC is relatively small.  
At stage L4.5, the lumen wall against vulC and the ventral side of vulD forms a smooth 
curve. (L4.6)  8 hr; the “fingers” between vulB2 and vulC (arrow) are pointed ventrally. 
(L4.7)  vulFs have migrated closer such that the lumen is narrowed in the dorsal section 
(arrow).  The approximate cutoff is when the width of the channel is less than the width 
of the vulD nucleus.  (L4.8) Lumen is partially collapsed.  (L4.9)  10 hr; lumen is 
completely collapsed  
 
Supplemental Figure 2.  The scheme for construction of enhancer-!-pes-10::GFP 
constructs by fusion-PCR.  The !-pes-10::GFP fragment was amplified from a vector 
containing the fusion (pP97.78) using primers PGdo and PGup3 (see Supplemental 
Materials for primer sequences). The candidate enhancer region was amplified from C. 
elegans genomic DNA using region-specific primers RGNxf and RGNxr. The 5' end of 
RGNxr primers contained a region complementary to the PGup3 primer, allowing for 
fusion PCR. The second round of amplification was done with primers RGNxf and 
PGdi3, using a mixture of the !-pes-10::GFP fragment and the candidate enhancer 
region fragment as the template. The primer PGdi3 is inset by 40 bases from the PGdo 
primer. This scheme minimizes the number of region-specific primers needed (two per 
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candidate region) while reducing the possibility of misprimed product by the use of 
partially nested reaction (by the use of PGdo/PGdi3 pair).   





























































          III-36
0 k 2 k 3 k 4 k 5 k 6 k 7 k 8 k 9 k1 k













vulE, vulF, pharyngeal muscle, body wall muscle
vulC, vulD
vulva (diffuse), pharyngeal muscle, body wall muscle
background only
















C. briggsae alignment chrX
C. briggsae alignment chrV
C. briggsae alignments chrIV
          III-37
Supplemental Figure 1
          III-38
Supplemental Figure 2 
          III-39
Gene Expression (L4 or adult) C. briggsae ortholog Reference
B0034.1 E, F CBG02550 Inoue, 2002
bam-2 F CBG04211 Colavita, 2003
C55C3.5 F CBG19878 Inoue, 2005
col-48 B1, B2, C, D* CBG04191 see Materials and Methods
daf-6 E, F CBG07607 Perens, 2005
egl-26 B, D, E CBG06994 Hanna-Rose, 2002
F48B9.5 C, D CBG14076 Gift of Hope Lab
grd-5 B1, B2, D CBG01473 Hao, 2006
grd-12 C CBG01466 Hao, 2006
grl-1† none in vulva CBG09376
grl-4 A, B1, B2, D CBG05832 Hao, 2006
grl-10 A, B1, B2 CBG20585 Hao, 2006
grl-15 B1, B2, C, D, E CBG24285 Hao, 2006
lin-11 all vulval cells CBG12236 Gupta, 2003
pax-2 D CBG13498‡ Gift of Chamberlin Lab
sqv-4 C, D, E, F CBG09668 Hwang, 2002
syg-2 E, F CBG07568 Shen, 2004
cdh-3 C, D, E, F CBG00038 Pettitt, 1996
ceh-2 B1, B2, C CBG20241 Inoue, 2002
cog-1 all vulval cells CBG20882 Palmer, 2002
col-7 A none identified see Materials and Methods
dhs-31 B1, B2, D CBG03429 Inoue, 2002
egl-17 C, D (E, F in late L3) CBG08160 Burdine, 1998
egl-38 F none identified‡ Rajakumar, 2007
lin-29 all vulval cells CBG02753 Bettinger, 1996; 1997
lin-3 F none identified Chang, 1999
lin-39 A CBG09167 Wagmaister, 2006
nas-37 B CBG01954 Davis, 2004
nhr-67 A, B, C CBG06024 Fernandes, 2007
pepm-1 C, D, E, F CBG04636 Inoue, 2002
unc-53 C none identified Stringham, 2002
zmp-1 A, D, E CBG09053 Inoue, 2002; Wang, 2000
†grl-1 was included in this analysis because unpublished preliminary reports suggested grl-
1 expression in vulval cells. However, subsequent analyses found no evidence of grl-1 
expression in vulval cells (Hao et al., 2006).
Genes in boldface were analyzed in this study.  Orthology was based on WS140.
Table 1: Genes expressed in the C. elegans vulva
*L4 expression; adults express in all cells
‡PAX 2/5/8 genes pax-2 and egl-38 are apparently derived from a gene duplication event in 
the C. elegans lineage after the C. elegans/C. briggsae split.
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Region Gene Score Chrom. coordinates Expression
RGN7 grl-4 125 IV:7311259..7311452 vulA, vulB, vulD
RGN8 F48B9.5 114 X:2149352..2149526 none
RGN9 syg-2 114 X:14654526..14654706 vulva/uterine muscle
RGN10 grl-4 111 IV:7311157..7311350 none
RGN11 grl-1* 109 V:5533670..5533860 head neuron
RGN12 pax-2 102† IV:4204408..4204605 vulC, vulD
RGN13 bam-2 100 I:2957958..2958142 none
RGN14 col-48 99 I:3010421..3010614 vulB1, vulC, vulD, hyp7, neuron, body 
wall muscle
RGN15 sqv-4 99 V:10661863..10662060 pharyngeal muscle, intestine, neurons
RGN16 F48B9.5 97 X:2149252..2149439 vulA, vulB, vulC
RGN17 sqv-4 95 V:10662486..10662658 vulC, vulD
RGN18 syg-2 95 X:14654708..14654874 uterus
RGN19 grl-1* 94 V:5533789..5533958 none
RGN20 syg-2 94 X:14654369..14654563 pharyngeal muscle
RGN21 grl-4 93 IV:7311360..7311544 vulva (diffuse), head neurons
RGN22 F48B9.5 91 X:2149444..2149620 none
RGN23 grl-4 91 IV:7311501..7311695 vulva muscle, rectal epithelial
RGN24 grd-5 90 V:8618587..8618779 intestine, neurons
RGN25 grl-4 90 IV:7311056..7311253 vulva muscle, body wall muscle
RGN26 pax-2 90† IV:4204763..4204956 none
RGN27 syg-2 89 X:14654626..14654769 vulva muscle, uterine muscle
RGN28 sqv-4 86 V:10661980..10662177 vulE, vulF, pharyngal muscle, body 
wall muscle
RGN29 col-48 84 I:3010289..3010487 NO LINES
RGN30 sqv-4 84 V:10662590..10662767 vulva (diffuse), pharyngeal muscle, 
body wall muscle
RGN31 sqv-4 84 V:10662386..10662575 NO LINES
RGN32 sqv-4 84 V:10661486..10661684 none
RGN33 grl-10 83 V:7773889..7774085 none
RGN34 bam-2 82 I:2958056..2958247 NO LINES
RGN35 sqv-4 81 V:10662745..10662939 pharyngeal muscle
RGN36 pax-2 81† IV:4205426..4205618 NO LINES
RGN37 grl-10 78 V:7773781..7773979 none
RGN38 pax-2 78† IV:4205981..4206169 NO LINES
RGN39 bam-2 77 I:2958370..2958560 none
RGN40 sqv-4 77 V:10661750..10661948 NO LINES
RGN41 F48B9.5 76 X:2150334..2150528 pharyngeal muscle
RGN42 grl-15 76 III:12236244..12236442 intestine, coelomocytes
RGN43 sqv-4 76 V:10661295..10661492 NO LINES
RGN44 daf-6 75 X:14887363..14887561 vulva (diffuse), lateral hypodermis
RGN45 grl-10 75 V:7773135..7773333 NO LINES
RGN46 pax-2 75† IV:4205882..4206068 NO LINES
RGN47 pax-2 75† IV:4205708..4205906 NO LINES
RGN48 pax-2 75† IV:4205539..4205734 intestine, neurons
RGN49 pax-2 75† IV:4205240..4205432 NO LINES
RGN50 pax-2 75† IV:4204972..4205168 NO LINES
RGN51 B0034.1 74 II:5969843..5970039 NO LINES
RGN52 daf-6 74 X:14887906..14888097 NO LINES
RGN53 grd-5 74 V:8618686..8618857 NO LINES
RGN54 grl-4 73 IV:7311606..7311797 NO LINES
Table 2.  Candidate enhancer regions tested
†normalized from 50-bp score.
*grl-1 was included in this analysis because unpublished preliminary reports suggested grl-1 
expression in vulval cells. However, subsequent analyses found no evidence of grl-1 
expression in vulval cells (Hao et al., 2006).
Regions in bold exhibit vulval expression.  This work focused on RGNs with scores above 85 
(RGN7-RGN28).  Chromosomal coordinates are based on WormBase WS167 data set.      
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Region Gene Chrom. coordinates Vulva expression
RGN7a grl-4 IV:7311373..7311452 bright, vulB, vulC, vulD
RGN7b grl-4 IV:7311317..7311396 none
RGN7c grl-4 IV:7311260..7311339 faint (diffuse)
RGN12a pax-2 IV:4204526..4204605 none
RGN12b pax-2 IV:4204468..4204547 none
RGN12c pax-2 IV:4204409..4204488 none
RGN14a col-48 I:3010421..3010500 none
RGN14b col-48 I:3010477..3010556 bright, vulB, vulC, vulD
RGN14c col-48 I:3010534..3010613 none
RGN16a F48B9.5 X:2149360..2149439 none
RGN16b F48B9.5 X:2149307..2149386 none
RGN16c F48B9.5 X:2149253..2149332 none
RGN28a sqv-4 V:10662098..10662177 faint, vulE, vulF
RGN28b sqv-4 V:10662040..10662119 none
RGN28c sqv-4 V:10661981..10662060 none
Table 3.  Candidate 80-bp regions
Regions in bold exhibit vulval expression.  Chromosomal coordinates are based 
on WormBase WS167 data set.
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DNA bait Prey Comment
RGN7 (grl-4) None DNA "bait" highly self-active
RGN12 (pax-2) NHR-102 HIS positive only, but rare hit
ZTF-16 HIS positive only, but rare hit
RGN14 (col-48) CEH-22 HIS positive only
SEM-4 HIS positive only
RGN16 (F48B9.5) CEY-1 Double positive
NHR-43 Double positive
RGN17 (sqv-4) NHR-74 HIS positive only, but rare hit
ZTF-16 Double positive, and rare hit
RGN30 (sqv-4) None
Table 4.  Results of the yeast one-hybrid analysis
















RGN12 + 0 0 7 100 70 20 7 37
RGN12 nhr-102 0 15* 21 94 87 23 0 31
RGN12 ztf-16 2 6 6 97 73 5† 3 43
RGN16 + 96 78 39 39 8 0 0 51
RGN16 cey-1 100 90 75‡ 70§ 55¶ 0 0 20
RGN16 nhr-43 87 91 60|| 51 3 0 0 65
RGN17 + 0 2 4 98 85 1 4 46
RGN17 ztf-16 0 5 0 95 75 5 0 20
Table 5.  A subset of Y1H positives effect enhancer expression.
Worms were grown and scored at 20˚C.  P values were calculated using Fisher's 
exact test, comparing the fraction of cells, of the indicated cell type, that express the 
transgene versus those that do not and by comparing the expression of the 
transgene in a mutant versus a wild type background.  P < 0.05 considered 
significant and represented by bold type.  *, P = 0.0163; †, P = 0.0734; ‡, P = 
0.0086; §, P = 0.0334; ¶, P < 0.0001; ||, P = 0.0392.         













F48B9.5 + 1.08 (0.05) 1.15 (0.07) 1.87 (0.32) 5.47 (0.31) 8.66 (0.57)
F48B9.5 cey-1 0.73 (0.04) 0.74 (0.04) 2.32 (0.27) 5.79 (0.44) 7.19 (0.50)
F48B9.5 nhr-43 0.84 (0.03) 1.43 (0.22) 1.96 (0.30) 5.43 (0.25) 7.51 (0.31)
pax-2 + 11 (6) 41 (7) 74 (15) 88 (13) 93 (18)
pax-2 nhr-102 4 (1) 32 (5) 65 (11) 54 (14) 69 (14)
pax-2 ztf-16 14 (4) 138 (23) 94 (13) 93 (9) 53 (10)
Supplemental Table 1.  Relative GFP intensity of F48B9.5 and pax-2 
expression in vulD during the L4 sub-stages
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 During the development of multicellular organisms individual cells assume vastly 
divergent structural and functional roles.  These roles range from the transmission of 
chemical signals to the absorption of nutrients to the reinforcement of anatomical shape.  
Underlying this wide-ranging diversification are gene regulatory networks (GRNs); logic 
maps that describe the intricate connections between signaling molecules, transcription 
factors, cis-regulatory modules, and target genes.  Mapping these networks facilitates a 
better understanding of cell-fate patterning and enables us to make predictions about 
developmental processes.    
 While GRNs are being investigated in other systems and developmental 
processes, the C. elegans vulva provides us with an excellent opportunity for studying a 
relatively simple example of organogenesis.  As shown in this thesis, the worm is a 
highly tractable system for conducting genetic, molecular biological, and biochemical 
analysis; and while the majority of networks under scrutiny in other systems focus on 
processes occurring during embryogenesis, the vulva provides us with a post-embryonic 
model.  Also, its level of complexity strikes an elegant balance between the almost 
overwhelming complexity of mammalian organogenesis and the relative simplicity of 
single cell-type differentiation and specification.   
 While previous work had identified several aspects of transcriptional regulation 
during late-stage vulval organogenesis, in Chapter 2 I highlight my work in the initial 
consolidation and mapping of this data into a cohesive network diagram.  Classical 
forward genetic screens (i.e., by EMS mutagenesis) are biased towards isolating mutants 
with strong phenotypes that act through nonredundant mechanisms.  Since previous 
mutagenesis screens likely identified the majority of genes in this category, I utilized a 
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reverse genetic screen to identify additional genes, including those with more subtle 
effects, involved in late stage vulval organogenesis.  Utilizing RNA interference (RNAi) 
to systematically disrupt the function of 836 known and putative C. elegans transcription 
factors in a zmp-1::GFP (zinc metalloproteinase) background, we identified nhr-67 
(ortholog of Drosophila tailless) and nhr-113 (orphan nuclear hormone receptor) as 
positive regulators of zmp-1 expression in vulA cells.  nhr-113’s role in vulval 
organogenesis is possibly limited to regulation of differentiation in the vulA cell type.  
This is an excellent example of a gene involved in a subtle aspect of the vulval GRN that 
was missed by classical screening methods (Chapter 2).   
 A key component of GRNs are the cis-regulatory modules that mediate the 
spatiotemporal expression patterns of genes.  Using Cistematic, a software package that 
incorporates the phylogenetic-footprinting and motif-finding capabilities of MEME, 
AlignACE, Co-Bind, and Footprinter for identifying cis-regulatory elements (1), we 
identified four conserved motifs upstream of the ZMP-1 translational start site.  By 
deleting these motifs in the zmp-1::GFP transgene, three of the four motifs were revealed 
to possess cis-regulatory activity.  One of these motifs includes the first example, in the 
vulva, of an enhancer that drives expression in unexpected cells, thus indicating the 
possible existence of a vulva-affiliated repressor element (Chapter 2). 
 Furthering our analysis of cis-regulation of transcription during vulval 
development, we utilized bioinformatic techniques to identify nine ~ 200-bp vulva-
specific enhancer elements associated with six genes (Chapter 3).  Yeast one-hybrid 
analysis of six of these elements revealed five transcription factors that bind these regions 
in yeast.  Additional analysis of these transcription factors identified ZTF-16 as a 
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regulator of cell-fate specification in the vulva.  At present, it is not known if any of the 
linkages in our current vulval GRN model are direct.  The ZTF-16/pax-2 interaction, 
however, may represent a direct regulatory connection.   
 Further characterization of the interactors identified by the yeast one-hybrid 
screen, in particular ztf-16, is necessary for defining their roles, if any, in vulval 
differentiation.  Using our knowledge of the provisional vulval GRN it would be 
informative to conduct a series of pairwise tests with the ztf-16 mutant and ztf-16::GFP 
reporter strains.  cog-1, egl-38, lin-11, lin-29, and nhr-67 are the major regulators of 
vulval differentiation.  By assaying ztf-16 expression patterns in backgrounds mutant for 
these genes, and conversely, by assaying their expression patterns in a ztf-16 mutant 
background, we could elucidate ztf-16’s potential position and role in the regulatory 
network.  Determing whether the protein-DNA interactions identified in yeast occur in 
the worm is also intriguing as we do not know whether any of the linkages in the current 
GRN are direct.  To determine whether ZTF-16 directly regulates pax-2 and sqv-4 
expression, additional experiments could be performed.  Electrophoretic mobility shift 
assays (EMSA) with a variety of DNA probes (full-length, subdivided, and mutated RGN 
sequences) may verify protein-DNA interactions in vitro and fine-tune our knowledge of 
the actual binding sites.  For in vivo analysis of binding, a series of transgenic reporters 
could be constructed.  For example, the ~ 200-bp RGN sequences could be deleted from 
the more-complete reporter constructs and expression patterns between the two could be 
compared.  The spatial and temporal expression patterns of these mutated transgenes 
would then need to be compared in wild-type and mutant backgrounds.   
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 Considering that there are 934 predicted transcription factors in the C. elegans 
genome (2) and that phenotypes have only been identified for a fraction of these, it is 
likely that there are other transcription factors that are involved in the vulval GRN.  
These factors may act redundantly, or in parallel with each other to direct more subtle 
aspects of vulval differentiation, and consequently may have been missed in previous 
screens.  Our strategy described in Chapter 3 for identifying vulval enhancer elements 
was limited to the region 2 kb upstream of the ATG start site.  Enhancer elements, 
however, have been shown to exist outside of this region (3).  It would be relatively 
simple to adapt our procedures to search for elements further upstream, in 3’ regions, and 
in introns.  Yeast one-hybrid analysis could again be utilized for identifying additional 
protein-DNA interactions.   
 Microarray technology has been successfully used for expanding the knowledge 
of several gene regulatory networks as they effectively determine the gene expression 
profiles of specific cells and tissues (4–6).  Additionally, an adaptation of this technology, 
the combination of chromatin immunoprecipitation and microarrays (ChIP-chip), has 
been useful for identifying protein-DNA interactions (3, 6, 7).  There are obstacles to 
modifying this technology for use in the vulval model.  Mainly, due to the worm’s small 
size, the vulva cannot be easily dissected from the animal for the harvesting of the 
material needed for these assays.  Application of micromanipulator technology coupled 
with mRNA amplification protocols, however, holds promise as an effective way of 
overcoming this barrier.  The combination of these approaches will likely extend our 
understanding of the vulval gene regulatory network.  Cross-comparison of a more-
thoroughly defined vulval network with genomic networks in other systems can elucidate 
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evolutionary diversification of the mechanisms controlling cellular differentiation, and 
enhance our knowledge of developmental processes in general. 
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